{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:49:36Z","timestamp":1791456576342,"version":"4.3.4"},"reference-count":249,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03396-2","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:53:35Z","timestamp":1791453215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ablation\u2013immunotherapy synergy in cancer: mechanisms of the abscopal effect, emerging clinical applications, and translational roadmaps for next-generation onco-immunology"],"prefix":"10.1007","volume":"43","author":[{"given":"Mohammed Ali","family":"Hama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Adnan","family":"Madhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhang Hameed","family":"Awlqadr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awa Hama Amin","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawa Abdalrahim","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahand Kamal","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivar Hama Tahir","family":"Kareem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihad Ebrahim","family":"Hama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shnya Rahman","family":"Hamalaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar Mohammed","family":"AL-Farga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"3396_CR1","doi-asserted-by":"publisher","unstructured":"Abdul\u2010Rahman T, Ghosh S, Badar SM, Nazir A, Bamigbade GB, Aji N, Roy P, kachani H, Garg NK, Lawal L, Bliss ZSB, Awuah WA, Atallah O, Adebusoye FT, Teslyk TP, Sikora K, Horbas, VA The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review. European j Med Rzes. 2024; https:\/\/doi.org\/10.1186\/s40001-024-01711-z","DOI":"10.1186\/s40001-024-01711-z"},{"issue":"1","key":"3396_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003717","volume":"10","author":"S Abe","year":"2022","unstructured":"Abe S, Nagata H, Crosby EJ, Inoue Y, Kaneko K, Liu C-X, et al. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity. J Immunother Cancer. 2022;10(1):e003717. https:\/\/doi.org\/10.1136\/jitc-2021-003717.","journal-title":"J Immunother Cancer"},{"key":"3396_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1658681","author":"Y Abulajiang","year":"2025","unstructured":"Abulajiang Y, Wu Y, He Y. The dual nature of immunotherapy in female reproductive disorders: immune homeostasis and clinical challenges. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1658681.","journal-title":"Front Immunol"},{"issue":"14","key":"3396_CR4","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1039\/D5CC05854F","volume":"62","author":"M Aili","year":"2026","unstructured":"Aili M, Ma R, Cui Y, Abulaizi M, Alifu N, Ma C, Dong B. Nanotechnology empowered photodynamic therapy: a paradigm shift from local ablation to systemic immunity. Chem Commun. 2026;62(14):4188\u2013210. https:\/\/doi.org\/10.1039\/D5CC05854F","journal-title":"Chem Commun"},{"key":"3396_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adk4594","author":"H Alamir","year":"2025","unstructured":"Alamir H, Wong CCW, Alsubaiti A, Edmunds GL, Alismail M, Huynh L, et al. TIM3 is a context-dependent coregulator of cytotoxic T cell function. Sci Signal. 2025. https:\/\/doi.org\/10.1126\/scisignal.adk4594.","journal-title":"Sci Signal"},{"key":"3396_CR6","doi-asserted-by":"publisher","unstructured":"Albarr\u00e1n V, Rom\u00e1n MS, Pozas J, Chamorro J, Rosero DI, Guerrero P, Calvo JC, Gonz\u00e1lez C, Quevedo CGd, Aguado PPd, Moreno JA, Cort\u00e9s A, Soria A Adoptive T cell therapy for solid tumors: current landscape and future challenges. Front Immunol. 2024; https:\/\/doi.org\/10.3389\/fimmu.2024.1352805","DOI":"10.3389\/fimmu.2024.1352805"},{"issue":"5","key":"3396_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/cai2.53","volume":"2","author":"S Ali Mohammad","year":"2023","unstructured":"Ali Mohammad S, Hak A, Pogu SV, Rengan AK. Radiotherapy, photodynamic therapy, and cryoablation-induced abscopal effect: challenges and future prospects. Cancer Innov. 2023;2(5):323\u201345. https:\/\/doi.org\/10.1002\/cai2.53.","journal-title":"Cancer Innov"},{"issue":"8","key":"3396_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006608","volume":"11","author":"M Alshebremi","year":"2023","unstructured":"Alshebremi M, Tomchuck SL, Myers JT, Kingsley DT, Eid S, Abiff M, et al. Functional tumor cell-intrinsic STING, not host STING, drives local and systemic antitumor immunity and therapy efficacy following cryoablation. J Immunother Cancer. 2023;11(8):e006608. https:\/\/doi.org\/10.1136\/jitc-2022-006608.","journal-title":"J Immunother Cancer"},{"key":"3396_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1111796","author":"SS Attalla","year":"2023","unstructured":"Attalla SS, Taifour T, Muller WJ. Tailoring therapies to counter the divergent immune landscapes of breast cancer. Front Cell Dev Biol. 2023. https:\/\/doi.org\/10.3389\/fcell.2023.1111796.","journal-title":"Front Cell Dev Biol"},{"key":"3396_CR10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230063","author":"AV Ayala","year":"2023","unstructured":"Ayala AV, Hsu C-Y, Oles RE, Matsuo K, Loomis LR, Buzun E, et al. Commensal bacteria promote type I interferon signaling to maintain immune tolerance in mice. The J Exp Med. 2023. https:\/\/doi.org\/10.1084\/jem.20230063.","journal-title":"The J Exp Med"},{"issue":"9","key":"3396_CR11","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s10439-021-02833-9","volume":"49","author":"VS Bachu","year":"2021","unstructured":"Bachu VS, Kedda J, Suk I, Green JJ, Tyler B. High-intensity focused ultrasound: a review of mechanisms and clinical applications. Ann Biomed Eng. 2021;49(9):1975\u201391. https:\/\/doi.org\/10.1007\/s10439-021-02833-9.","journal-title":"Ann Biomed Eng"},{"key":"3396_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1384121","volume":"15","author":"L Berland","year":"2024","unstructured":"Berland L, Gabr Z, Chang M, Ili\u00e9 M, Hofman V, Rignol G, et al. Further knowledge and developments in resistance mechanisms to immune checkpoint inhibitors. Front Immunol. 2024;15:1384121. https:\/\/doi.org\/10.3389\/fimmu.2024.1384121.","journal-title":"Front Immunol"},{"key":"3396_CR13","doi-asserted-by":"publisher","first-page":"1038347","DOI":"10.3389\/fimmu.2022.1038347","volume":"13","author":"RJE Bijgaart","year":"2022","unstructured":"Bijgaart RJE, Mekers V, Schuurmans F, Raaijmakers TK, Wassink M, Veltien A, Dumont E, Heerschap A, F\u00fctterer JJ, Adema GJ. Mechanical high-intensity focused ultrasound creates unique tumor debris enhancing dendritic cell-induced T cell activation. FrontImmunol. 2022;13:1038347\u20131038347. https:\/\/doi.org\/10.3389\/fimmu.2022.1038347","journal-title":"FrontImmunol"},{"key":"3396_CR14","doi-asserted-by":"publisher","first-page":"617365","DOI":"10.3389\/fimmu.2021.617365","volume":"12","author":"RJE v. d. Bijgaart","year":"2021","unstructured":"v. d. Bijgaart RJE, Schuurmans F, F\u00fctterer JJ, Verheij M, Cornelissen LAM, Adema GJ. Immune modulation plus tumor ablation: adjuvants and antibodies to prime and boost anti-tumor immunity in situ. Front Immunol. 2021;12:617365\u2013617365. https:\/\/doi.org\/10.3389\/fimmu.2021.617365.","journal-title":"Front Immunol"},{"issue":"45","key":"3396_CR15","doi-asserted-by":"publisher","first-page":"31411","DOI":"10.1039\/d3ra01153d","volume":"13","author":"R Blanchard","year":"2023","unstructured":"Blanchard R, Adjei IM. Engineering the glioblastoma microenvironment with bioactive nanoparticles for effective immunotherapy. RSC Adv. 2023;13(45):31411\u201325. https:\/\/doi.org\/10.1039\/d3ra01153d.","journal-title":"RSC Adv"},{"key":"3396_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-025-02083-6","author":"S Bodard","year":"2025","unstructured":"Bodard S, Moussa AM, Vaynrub M, Bartelstein M, Santos-Martin E, Maybody M, et al. Percutaneous microwave ablation of bone lesions: a retrospective cohort study. Insights into Imaging. 2025. https:\/\/doi.org\/10.1186\/s13244-025-02083-6.","journal-title":"Insights into Imaging"},{"key":"3396_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1681777","author":"AS Brinkman","year":"2025","unstructured":"Brinkman AS, Muthuswamy R, Dong B, Edwards RP, Kalinski P. IFN\u03b3-mediated suppression of alternative NF-\u03baB in tumor-resident myeloid cells promotes selective recruitment of cytotoxic but not regulatory T cells. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1681777.","journal-title":"Front Immunol"},{"key":"3396_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1151632","author":"AE Brunell","year":"2023","unstructured":"Brunell AE, Lahesmaa R, Autio A, Thotakura AK. Exhausted T cells hijacking the cancer-immunity cycle: assets and liabilities. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1151632.","journal-title":"Front Immunol"},{"key":"3396_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1135456","author":"S Bruni","year":"2023","unstructured":"Bruni S, Mercogliano MF, Mauro F, Russo RIC, Schillaci R. Cancer immune exclusion: breaking the barricade for a successful immunotherapy. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1135456.","journal-title":"Front Oncol"},{"key":"3396_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1405486","author":"S Budhu","year":"2024","unstructured":"Budhu S, Kim K, Yip W, Rosa SL, Jebiwott S, Cai LQ, et al. Comparative study of immune response to local tumor destruction modalities in a murine breast cancer model. Front Oncol. 2024. https:\/\/doi.org\/10.3389\/fonc.2024.1405486.","journal-title":"Front Oncol"},{"issue":"1","key":"3396_CR21","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1038\/s41467-021-24132-6","volume":"12","author":"BJ Burbach","year":"2021","unstructured":"Burbach BJ, O\u2019Flanagan SD, Shao Q, Young KM, Slaughter JR, Rollins MR, et al. Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells. Nat Commun. 2021;12(1):3862\u20133862. https:\/\/doi.org\/10.1038\/s41467-021-24132-6.","journal-title":"Nat Commun"},{"issue":"6","key":"3396_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41577-023-00973-8","volume":"24","author":"LH Butterfield","year":"2023","unstructured":"Butterfield LH, Najjar YG. Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations. Nat Rev Immunol. 2023;24(6):399\u2013416. https:\/\/doi.org\/10.1038\/s41577-023-00973-8.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3396_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41392-025-02140-y","volume":"10","author":"Y Cai","year":"2025","unstructured":"Cai Y, Chai T, Nguyen W, Liu J, Xiao E, Ran X, et al. Phototherapy in cancer treatment: strategies and challenges. Signal Transduct Target Ther. 2025;10(1):115\u2013115. https:\/\/doi.org\/10.1038\/s41392-025-02140-y.","journal-title":"Signal Transduct Target Ther"},{"key":"3396_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1373738","author":"P Castorina","year":"2024","unstructured":"Castorina P, Castiglione F, Ferini G, Forte S, Martorana E, Giuffrida D. Mathematical modeling of the synergistic interplay of radiotherapy and immunotherapy in anti-cancer treatments. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1373738.","journal-title":"Front Immunol"},{"key":"3396_CR25","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.250263","author":"CS Centner","year":"2026","unstructured":"Centner CS, Choi R, Georgiades CS, Yarchoan M, Weiss CR. Thermal and nonthermal liver ablation: mechanistic foundations, clinical implementation, immunologic trial design, and artificial intelligence. Radiology. 2026. https:\/\/doi.org\/10.1148\/radiol.250263.","journal-title":"Radiology"},{"issue":"3","key":"3396_CR26","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.250263","volume":"318","author":"CS Centner","year":"2026","unstructured":"Centner CS, Choi R, Georgiades CS, Yarchoan M, Weiss CR. Thermal and nonthermal liver ablation: mechanistic foundations, clinical implementation, immunologic trial design, and artificial intelligence. Radiology. 2026;318(3):e250263. https:\/\/doi.org\/10.1148\/radiol.250263.","journal-title":"Radiology"},{"key":"3396_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1033000","volume":"13","author":"S Chen","year":"2022","unstructured":"Chen S, Zeng X, Su T, Xiao H, Lin M, Peng Z, et al. Combinatory local ablation and immunotherapies for hepatocellular carcinoma: rationale, efficacy, and perspective. Front Immunol. 2022;13:1033000. https:\/\/doi.org\/10.3389\/fimmu.2022.1033000.","journal-title":"Front Immunol"},{"key":"3396_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00551-z","author":"X Chen","year":"2024","unstructured":"Chen X, Xu Z, Li T, Thakur A, Wen Y, Zhang K, et al. Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy. Biomark Res. 2024. https:\/\/doi.org\/10.1186\/s40364-023-00551-z.","journal-title":"Biomark Res"},{"key":"3396_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1094009","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, Meng L, Zhang J, Zhang X. Progress in the cryoablation and cryoimmunotherapy for tumor. Front Immunol. 2023;14:1094009. https:\/\/doi.org\/10.3389\/fimmu.2023.1094009.","journal-title":"Front Immunol"},{"key":"3396_CR30","doi-asserted-by":"publisher","DOI":"10.3892\/or.2024.8755","author":"S Cheng","year":"2024","unstructured":"Cheng S, Tu K-Y, Lee H-H. The dynamic duo: a narrative review on the synergy between stereotactic body radiotherapy and immunotherapy in lung cancer treatment (Review). Oncology Rep. 2024. https:\/\/doi.org\/10.3892\/or.2024.8755.","journal-title":"Oncology Rep"},{"key":"3396_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1355812","author":"RC Chick","year":"2024","unstructured":"Chick RC, Ruff SM, Pawlik TM. Neoadjuvant systemic therapy for hepatocellular carcinoma. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1355812.","journal-title":"Front Immunol"},{"key":"3396_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.iotech.2025.101076","author":"J Chiffelle","year":"2025","unstructured":"Chiffelle J, Genolet R, Michielin O, Harari A. Harnessing TCR repertoires: predictive insights and therapeutic monitoring in cancer immunotherapy. Immuno-Oncol Technol. 2025. https:\/\/doi.org\/10.1016\/j.iotech.2025.101076.","journal-title":"Immuno-Oncol Technol"},{"issue":"11","key":"3396_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13111114","volume":"13","author":"T Chikovani","year":"2025","unstructured":"Chikovani T, Magen E. In situ vaccination by tumor ablation: principles and prospects for systemic antitumor immunity. Vaccines Basel. 2025;13(11):1114.","journal-title":"Vaccines Basel"},{"issue":"11","key":"3396_CR34","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3390\/vaccines13111114","volume":"13","author":"T Chikovani","year":"2025","unstructured":"Chikovani T, Magen E. In situ vaccination by tumor ablation: principles and prospects for systemic antitumor immunity. Vaccines. 2025;13(11):1114\u20131114. https:\/\/doi.org\/10.3390\/vaccines13111114.","journal-title":"Vaccines"},{"issue":"13","key":"3396_CR35","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.3390\/cancers17132102","volume":"17","author":"G Colonna","year":"2025","unstructured":"Colonna G. Overcoming barriers in cancer biology research: current limitations and solutions. Cancers. 2025;17(13):2102\u20132102. https:\/\/doi.org\/10.3390\/cancers17132102.","journal-title":"Cancers"},{"issue":"1","key":"3396_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-025-01739-6","volume":"18","author":"S Dai","year":"2025","unstructured":"Dai S, Chen Y, Cai W, Dong S, Zhao J, Chen L, et al. Combination immunotherapy in hepatocellular carcinoma: synergies among immune checkpoints, TKIs, and chemotherapy. J Hematol Oncol. 2025;18(1):85\u201385.","journal-title":"J Hematol Oncol"},{"key":"3396_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002038","author":"S Demaria","year":"2021","unstructured":"Demaria S, Guha C, Schoenfeld JD, Morris ZS, Monjazeb AM, Sikora AG, et al. Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose? J Immunother Cancer. 2021. https:\/\/doi.org\/10.1136\/jitc-2020-002038.","journal-title":"J Immunother Cancer"},{"issue":"6","key":"3396_CR38","doi-asserted-by":"publisher","first-page":"427","DOI":"10.5582\/bst.2023.01275","volume":"17","author":"Y Duan","year":"2023","unstructured":"Duan Y, Zhang H, Tan T, Ye W, Yin K-L, Yu Y, et al. The immune response of hepatocellular carcinoma after locoregional and systemic therapies: the available combination option for immunotherapy. Biosci Trends. 2023;17(6):427\u201344. https:\/\/doi.org\/10.5582\/bst.2023.01275.","journal-title":"Biosci Trends"},{"key":"3396_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01909-z","author":"Y Dutt","year":"2023","unstructured":"Dutt Y, Pandey RP, Dutt M, Gupta A, Vibhuti A, Vidi\u0107 J, et al. Therapeutic applications of nanobiotechnology. J Nanobiotechnol. 2023. https:\/\/doi.org\/10.1186\/s12951-023-01909-z.","journal-title":"J Nanobiotechnol"},{"issue":"12","key":"3396_CR40","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.3390\/genes14122118","volume":"14","author":"A Elwakeel","year":"2023","unstructured":"Elwakeel A, Bridgewater HE, Bennett J. Unlocking dendritic cell-based vaccine efficacy through genetic modulation\u2014how soon is now? Genes. 2023;14(12):2118\u20132118. https:\/\/doi.org\/10.3390\/genes14122118.","journal-title":"Genes"},{"key":"3396_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009063","author":"LA Emens","year":"2024","unstructured":"Emens LA, Romero P, Anderson AC, Bruno TC, Capitini CM, Collyar D, et al. Challenges and opportunities in cancer immunotherapy: a society for immunotherapy of cancer (SITC) strategic vision. J ImmunoTher Cancer. 2024. https:\/\/doi.org\/10.1136\/jitc-2024-009063.","journal-title":"J ImmunoTher Cancer"},{"key":"3396_CR42","doi-asserted-by":"publisher","unstructured":"Faria RM, Rosa SdSRF, Nunes GAMdA, Santos KS, Souza RPd, Benavides, ADI, Alves, AKdO, Silva AKAd, Rosa MF, Cardoso AAdA, Faria SdS, Berjano E, Rocha AFd, Santos \u00cdd, Gonz\u00e1lez\u2010Su\u00e1rez A. Particle swarm optimization solution for roll-off control in radiofrequency ablation of liver tumors: Optimal search for PID controller tuning. PLOS ONE 2025 https:\/\/doi.org\/10.1371\/journal.pone.0300445","DOI":"10.1371\/journal.pone.0300445"},{"issue":"1","key":"3396_CR43","doi-asserted-by":"publisher","first-page":"98618","DOI":"10.4329\/wjr.v17.i1.98618","volume":"17","author":"F Fazlollahi","year":"2025","unstructured":"Fazlollahi F, Makary MS. Precision oncology: the role of minimally-invasive ablation therapy in the management of solid organ tumors. World J Radiol. 2025;17(1):98618\u201398618. https:\/\/doi.org\/10.4329\/wjr.v17.i1.98618.","journal-title":"World J Radiol"},{"issue":"1","key":"3396_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80135-1","volume":"11","author":"BZ Fite","year":"2021","unstructured":"Fite BZ, Wang J, Kare AJ, Ilovitsh A, Chavez M, Ilovitsh T, et al. Immune modulation resulting from MR-guided high intensity focused ultrasound in a model of murine breast cancer. Sci Rep. 2021;11(1):927. https:\/\/doi.org\/10.1038\/s41598-020-80135-1.","journal-title":"Sci Rep"},{"issue":"3","key":"3396_CR45","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.semradonc.2023.03.012","volume":"33","author":"KJ Fitzgerald","year":"2023","unstructured":"Fitzgerald KJ, Schoenfeld JD. Radiotherapy dose in patients receiving immunotherapy. Semin Radiat Oncol. 2023;33(3):327\u201335. https:\/\/doi.org\/10.1016\/j.semradonc.2023.03.012.","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"3396_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41746-025-01471-y","volume":"8","author":"E Fountzilas","year":"2025","unstructured":"Fountzilas E, Pearce T, Baysal MA, Chakraborty A, Tsimberidou AM. Convergence of evolving artificial intelligence and machine learning techniques in precision oncology. npj Digit Med. 2025;8(1):75\u201375. https:\/\/doi.org\/10.1038\/s41746-025-01471-y","journal-title":"npj Digit Med"},{"key":"3396_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1218082","author":"Y Fu","year":"2023","unstructured":"Fu Y, Tang R, Zhao X. Engineering cytokines for cancer immunotherapy: a systematic review. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1218082.","journal-title":"Front Immunol"},{"issue":"2","key":"3396_CR48","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11547-024-01769-z","volume":"129","author":"F Galati","year":"2024","unstructured":"Galati F, Marra A, Cicciarelli F, Pasculli M, Maroncelli R, Rizzo V, Moffa G. Pediconi F Cryoablation for the treatment of breast cancer: immunological implications and future perspectives. Utopia or reality? La radiologia Med. 2024;129(2):222\u20138. https:\/\/doi.org\/10.1007\/s11547-024-01769-z","journal-title":"Utopia or reality? La radiologia Med"},{"key":"3396_CR49","doi-asserted-by":"publisher","first-page":"1203539","DOI":"10.3389\/fimmu.2023.1203539","volume":"14","author":"AV Garc\u00eda-Nieto","year":"2023","unstructured":"Garc\u00eda-Nieto AV, DeMaio A, Sterman DH. Cryoablation and immunity in non-small cell lung cancer: a new era of cryo-immunotherapy. Front Immunol. 2023;14:1203539\u20131203539. https:\/\/doi.org\/10.3389\/fimmu.2023.1203539.","journal-title":"Front Immunol"},{"key":"3396_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10715-7","author":"A Golebiewska","year":"2023","unstructured":"Golebiewska A, Fields RC. Advancing preclinical cancer models to assess clinically relevant outcomes. BMC Cancer. 2023. https:\/\/doi.org\/10.1186\/s12885-023-10715-7.","journal-title":"BMC Cancer"},{"issue":"12","key":"3396_CR51","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/s41590-024-02015-4","volume":"25","author":"S Goswami","year":"2024","unstructured":"Goswami S, Pauken KE, Wang L, Sharma P. Next-generation combination approaches for immune checkpoint therapy. Nat Immunol. 2024;25(12):2186\u201399. https:\/\/doi.org\/10.1038\/s41590-024-02015-4.","journal-title":"Nat Immunol"},{"key":"3396_CR52","doi-asserted-by":"publisher","DOI":"10.1200\/po.21.00512","volume":"6","author":"MA Gouda","year":"2022","unstructured":"Gouda MA, Huang HJ, Piha-Paul SA, Call SG, Karp DD, Fu S, et al. Longitudinal monitoring of circulating tumor DNA to predict treatment outcomes in advanced cancers. JCO Precis Oncol. 2022;6:e2100512. https:\/\/doi.org\/10.1200\/po.21.00512.","journal-title":"JCO Precis Oncol"},{"issue":"12","key":"3396_CR53","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1158\/0008-5472.Can-20-4026","volume":"81","author":"M Gr\u00f6nholm","year":"2021","unstructured":"Gr\u00f6nholm M, Feodoroff M, Antignani G, Martins B, Hamdan F, Cerullo V. Patient-derived organoids for precision cancer immunotherapy. Cancer Res. 2021;81(12):3149\u201355. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-4026.","journal-title":"Cancer Res"},{"issue":"1","key":"3396_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008386","volume":"12","author":"C Gu","year":"2024","unstructured":"Gu C, Wang X, Wang K, Xie F, Chen L, Ji H, et al. Cryoablation triggers type I interferon-dependent antitumor immunity and potentiates immunotherapy efficacy in lung cancer. J Immunother Cancer. 2024;12(1):e008386. https:\/\/doi.org\/10.1136\/jitc-2023-008386.","journal-title":"J Immunother Cancer"},{"key":"3396_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-022-00363-1","author":"L Guo","year":"2023","unstructured":"Guo L, Kong D, Liu J, Zhan L, Luo L, Zheng W, et al. Breast cancer heterogeneity and its implication in personalized precision therapy. Exp Hematol Oncol. 2023. https:\/\/doi.org\/10.1186\/s40164-022-00363-1.","journal-title":"Exp Hematol Oncol"},{"key":"3396_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1283843","author":"P Guo","year":"2024","unstructured":"Guo P, Zheng J, Pi X, Gao F, Zhao Y, Xie C, et al. Transarterial chemoembolization combined with radiofrequency ablation for medium and large hepatocellular carcinoma: insufficient ablation is associated with intrahepatic distant metastasis and extrahepatic metastasis. Front Oncol. 2024. https:\/\/doi.org\/10.3389\/fonc.2024.1283843.","journal-title":"Front Oncol"},{"issue":"1","key":"3396_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14002-5","volume":"25","author":"RQ Guo","year":"2025","unstructured":"Guo RQ, Li Y, Bie ZX, Peng J-Z, Li X. Microwave ablation of non-small cell lung cancer enhances local T-cell abundance and alters monocyte interactions. BMC Cancer. 2025;25(1):605. https:\/\/doi.org\/10.1186\/s12885-025-14002-5.","journal-title":"BMC Cancer"},{"key":"3396_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02111-x","author":"S Guo","year":"2023","unstructured":"Guo S, Gu D, Yang Y, Tian J, Chen X. Near-infrared photodynamic and photothermal co-therapy based on organic small molecular dyes. J Nanobiotechnol. 2023. https:\/\/doi.org\/10.1186\/s12951-023-02111-x.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"3396_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/jimr\/5006201","volume":"2025","author":"L Han","year":"2025","unstructured":"Han L, Wu T-J, Zhang Q, Qi A, Zhou X. Immune tolerance regulation is critical to immune homeostasis. J Immunol Res. 2025;2025(1):5006201. https:\/\/doi.org\/10.1155\/jimr\/5006201.","journal-title":"J Immunol Res"},{"key":"3396_CR60","doi-asserted-by":"publisher","first-page":"101859","DOI":"10.1016\/j.tranon.2023.101859","volume":"40","author":"N He","year":"2023","unstructured":"He N, Jiang J. Contribution of immune cells in synergistic anti-tumor effect of ablation and immunotherapy. Translational Oncology. 2023;40:101859\u2013101859. https:\/\/doi.org\/10.1016\/j.tranon.2023.101859.","journal-title":"Translational Oncology"},{"key":"3396_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04305-6","author":"M Hegde","year":"2025","unstructured":"Hegde M, Mishra A, Banerjee R, Bintee B, Alqahtani MS, Abbas M, et al. Bioresponsive engineered nanoparticles for immunomodulation. BMC Med. 2025. https:\/\/doi.org\/10.1186\/s12916-025-04305-6.","journal-title":"BMC Med."},{"issue":"1","key":"3396_CR62","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12943-023-01775-1","volume":"22","author":"L Hovhannisyan","year":"2023","unstructured":"Hovhannisyan L, Riether C, Aebersold DM, Medov\u00e1 M, Zimmer Y. CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks. Mol Cancer. 2023;22(1):82\u201382. https:\/\/doi.org\/10.1186\/s12943-023-01775-1.","journal-title":"Mol Cancer"},{"issue":"10","key":"3396_CR63","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/s43018-025-01018-w","volume":"6","author":"J Huang","year":"2025","unstructured":"Huang J, Theelen WSME, Belcaid Z, Najjar M, Geest Dvd, Singh D, Cherry C, Balan A, White JR, Wehr J, Karchin R, Niknafs N, Heuvel MMvd, Velculescu VE, Smith KN, Baas P. Anagnostou V Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer. Nat Cancer. 2025;6(10):1676\u201392.","journal-title":"Nat Cancer"},{"key":"3396_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1399926","author":"M Huang","year":"2024","unstructured":"Huang M, Cha Z, Liu R, Lin M, Gafoor NA, Kong T, et al. Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1399926.","journal-title":"Front Immunol"},{"key":"3396_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1124152","author":"T Huang","year":"2023","unstructured":"Huang T, Wu W, Wu J, Yang T, Zhang M, Long H, et al. Perfluorocarbon nanodrug induced oxygen self-enriching sonodynamic therapy improves cancer immunotherapy after insufficient radiofrequency ablation. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1124152.","journal-title":"Front Immunol"},{"key":"3396_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1717062","author":"X Hui","year":"2025","unstructured":"Hui X, Sun A, Zhao T, Wang H. Reprogramming the tumor microenvironment to overcome immunotherapy resistance in pancreatic cancer. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1717062.","journal-title":"Front Immunol"},{"key":"3396_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1148692","author":"C Iliadi","year":"2023","unstructured":"Iliadi C, Verset L, Bouchart C, Martinive P, Gestel DV, Krayem M. The current understanding of the immune landscape relative to radiotherapy across tumor types. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1148692.","journal-title":"Front Immunol"},{"issue":"4","key":"3396_CR68","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s11604-023-01516-w","volume":"42","author":"M Ito","year":"2023","unstructured":"Ito M, Abe S, Adachi S, Oshima Y, Takeuchi A, Ohashi W, et al. Solid tumours showing oligoprogression to immune checkpoint inhibitors have the potential for abscopal effects. Jpn J Radiol. 2023;42(4):424\u201334. https:\/\/doi.org\/10.1007\/s11604-023-01516-w.","journal-title":"Jpn J Radiol"},{"issue":"3","key":"3396_CR69","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/pharmaceutics16030411","volume":"16","author":"S Jahangiri","year":"2024","unstructured":"Jahangiri S, Yu FTH. Fundamentals and applications of focused ultrasound-assisted cancer immune checkpoint inhibition for solid tumors. Pharmaceutics. 2024;16(3):411\u2013411. https:\/\/doi.org\/10.3390\/pharmaceutics16030411.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3396_CR70","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/imr.13301","volume":"321","author":"S Janssens","year":"2023","unstructured":"Janssens S, Rennen S, Agostinis P. Decoding immunogenic cell death from a dendritic cell perspective. Immunol Rev. 2023;321(1):350\u201370. https:\/\/doi.org\/10.1111\/imr.13301.","journal-title":"Immunol Rev"},{"issue":"4","key":"3396_CR71","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41391-023-00702-1","volume":"27","author":"J Javier\u2010Desloges","year":"2023","unstructured":"Javier\u2010Desloges J, Dall\u2019Era M, Brisbane W, Chamie K, Washington SL, Chandrasekar T, et al. The state of focal therapy in the treatment of prostate cancer: the University of California collaborative (UC-Squared) consensus statement. Prostate Cancer Prostatic Dis. 2023;27(4):579\u201381. https:\/\/doi.org\/10.1038\/s41391-023-00702-1.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"3396_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.729359","author":"H Ji","year":"2021","unstructured":"Ji H, Ba Y, Ma S, Hou K, Mi S, Gao X, et al. Construction of interferon-gamma-related gene signature to characterize the immune-inflamed phenotype of glioblastoma and predict prognosis, efficacy of immunotherapy and radiotherapy [Original Research]. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.729359.","journal-title":"Front Immunol"},{"key":"3396_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1106644","author":"X Ji","year":"2023","unstructured":"Ji X, Jiang W, Wang J, Zhou B, Ding W, Liu S, et al. Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2022.1106644.","journal-title":"Front Immunol"},{"key":"3396_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1153066","author":"M Jiang","year":"2023","unstructured":"Jiang M, Fiering S, Shao Q. Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1153066.","journal-title":"Front Oncol"},{"issue":"1","key":"3396_CR75","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12951-024-02643-w","volume":"22","author":"Q Jiang","year":"2024","unstructured":"Jiang Q, Qiao B, Zheng J, Song W, Zhang N, Xu J, et al. Potentiating dual-directional immunometabolic regulation with nanomedicine to enhance anti-tumor immunotherapy following incomplete photothermal ablation. J Nanobiotechnol. 2024;22(1):364\u2013364. https:\/\/doi.org\/10.1186\/s12951-024-02643-w.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"3396_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40890-x","volume":"14","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Zhang Z, Wang W, Huang W, Chen C, Xi S, et al. Biology-guided deep learning predicts prognosis and cancer immunotherapy response. Nat Commun. 2023;14(1):5135. https:\/\/doi.org\/10.1038\/s41467-023-40890-x.","journal-title":"Nat Commun"},{"issue":"7","key":"3396_CR77","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1038\/s41401-024-01260-5","volume":"45","author":"J-Z Jiao","year":"2024","unstructured":"Jiao J-Z, Zhang Y, Zhang W, He M, Meng M, Liu T, et al. Radiofrequency radiation reshapes tumor immune microenvironment into antitumor phenotype in pulmonary metastatic melanoma by inducing active transformation of tumor-infiltrating CD8+ T and NK cells. Acta Pharmacol Sin. 2024;45(7):1492\u2013505. https:\/\/doi.org\/10.1038\/s41401-024-01260-5.","journal-title":"Acta Pharmacol Sin"},{"key":"3396_CR78","doi-asserted-by":"publisher","DOI":"10.1126\/science.adq1405","author":"K Jobin","year":"2025","unstructured":"Jobin K, Seetharama D, R\u00fcttger L, Fenton C, Kharybina E, Wirsching A, et al. A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals. Science. 2025. https:\/\/doi.org\/10.1126\/science.adq1405.","journal-title":"Science"},{"key":"3396_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1098326","author":"S Jolles","year":"2023","unstructured":"Jolles S, Giralt S, Kerre T, Lazarus HM, Mustafa SS, Ria R, et al. Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: a systematic literature review. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1098326.","journal-title":"Front Oncol"},{"key":"3396_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1640409","author":"M Ju","year":"2025","unstructured":"Ju M, Sun M, Li W, Zhang S. Case report: abscopal response and reversal of PD-1 resistance in a patient with nephroblastoma following radiofrequency ablation. Front Oncol. 2025. https:\/\/doi.org\/10.3389\/fonc.2025.1640409.","journal-title":"Front Oncol"},{"key":"3396_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40996-2","author":"X Kang","year":"2023","unstructured":"Kang X, Zhang Y, Song J, Wang L, Li W, Qi J, et al. A photo-triggered self-accelerated nanoplatform for multifunctional image-guided combination cancer immunotherapy. Nat Commun. 2023. https:\/\/doi.org\/10.1038\/s41467-023-40996-2.","journal-title":"Nat Commun"},{"key":"3396_CR82","doi-asserted-by":"publisher","unstructured":"Kareva I, Gevertz JL Mitigating non-genetic resistance to checkpoint inhibition based on multiple states of immune exhaustion. npj Syst Bio Appl. 2024; https:\/\/doi.org\/10.1038\/s41540-024-00336-6","DOI":"10.1038\/s41540-024-00336-6"},{"issue":"4","key":"3396_CR83","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10555-023-10150-x","volume":"42","author":"Y Keisari","year":"2023","unstructured":"Keisari Y, Kelson I. Tumor ablation induced anti-tumor immunity: destruction of the tumor in situ with the aim to evoke a robust anti-tumor immune response. Cancer Metastasis Rev. 2023;42(4):1065\u20138. https:\/\/doi.org\/10.1007\/s10555-023-10150-x.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"3396_CR84","doi-asserted-by":"publisher","first-page":"120","DOI":"10.21294\/1814-4861-2024-23-1-120-129","volume":"23","author":"AV Khachaturyan","year":"2024","unstructured":"Khachaturyan AV, \u0411y\u043b\u044b\u0447\u043a\u0438\u043d \u041fB. The abscopal effect: mechanism of occurrence and prospects of using it in therapy of metastatic cancer. Siberian J Oncol. 2024;23(1):120\u20139.","journal-title":"Siberian J Oncol"},{"key":"3396_CR85","doi-asserted-by":"crossref","unstructured":"Kim HC Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma? In Clin Mol Hepatol. 2023; (Vol. 29, pp. 984\u2013986): Korean Association for the Study of the Liver.","DOI":"10.3350\/cmh.2023.0275"},{"key":"3396_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1118845","author":"NJ Kim","year":"2023","unstructured":"Kim NJ, Yoon JH, Tuomi AC, Lee JJ, Kim D-H. In-situ tumor vaccination by percutaneous ablative therapy and its synergy with immunotherapeutics: an update on combination therapy. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1118845.","journal-title":"Front Immunol"},{"key":"3396_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1118845","volume":"14","author":"NJ Kim","year":"2023","unstructured":"Kim NJ, Yoon JH, Tuomi AC, Lee JJ, Kim D-H. In-situ tumor vaccination by percutaneous ablative therapy and its synergy with immunotherapeutics: an update on combination therapy. Front Immunol. 2023;14:1118845. https:\/\/doi.org\/10.3389\/fimmu.2023.1118845.","journal-title":"Front Immunol"},{"issue":"11","key":"3396_CR88","doi-asserted-by":"publisher","first-page":"6205","DOI":"10.1007\/s00464-024-11278-9","volume":"38","author":"RC Kim","year":"2024","unstructured":"Kim RC, Ceppa EP. Neuroendocrine tumor liver metastasis: moderate long-term outcomes supporting ablation. Surg Endosc. 2024;38(11):6205\u20136. https:\/\/doi.org\/10.1007\/s00464-024-11278-9.","journal-title":"Surg Endosc"},{"issue":"4","key":"3396_CR89","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1053\/j.tvir.2013.08.002","volume":"16","author":"EM Knavel","year":"2013","unstructured":"Knavel EM, Brace CL. Tumor ablation: common modalities and general practices. Tech Vasc Interv Radiol. 2013;16(4):192\u2013200. https:\/\/doi.org\/10.1053\/j.tvir.2013.08.002.","journal-title":"Tech Vasc Interv Radiol"},{"key":"3396_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1012676","author":"M Koutsi","year":"2025","unstructured":"Koutsi M, Stylianopoulos T, Mpekris F. Optimizing therapeutic outcomes with mechanotherapy and ultrasound sonopermeation in solid tumors. PLoS Comput Biol. 2025. https:\/\/doi.org\/10.1371\/journal.pcbi.1012676.","journal-title":"PLoS Comput Biol"},{"key":"3396_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.616058","volume":"11","author":"A Kov\u00e1cs","year":"2021","unstructured":"Kov\u00e1cs A, Bischoff P, Haddad H, Kov\u00e1cs G, Schaefer A, Zhou W, et al. Personalized image-guided therapies for local malignencies: interdisciplinary options for interventional radiology and interventional radiotherapy. Front Oncol. 2021;11:616058. https:\/\/doi.org\/10.3389\/fonc.2021.616058.","journal-title":"Front Oncol"},{"key":"3396_CR92","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2022.5450","author":"G Kuang","year":"2022","unstructured":"Kuang G, Wang Z, Luo C, Luo J, Wang J. Mechanism of exosomes in the tumor microenvironment in the abscopal effect (Review). Int J Oncol. 2022. https:\/\/doi.org\/10.3892\/ijo.2022.5450.","journal-title":"Int J Oncol"},{"key":"3396_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.690188","author":"J-Z Lai","year":"2021","unstructured":"Lai J-Z, Zhu Y-Y, Liu Y, Zhou L-L, Hu L, Chen L, et al. Abscopal effects of local radiotherapy are dependent on tumor Immunogenicity [Original Research]. Front Oncol. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.690188.","journal-title":"Front Oncol"},{"key":"3396_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1233376","author":"J Lee","year":"2023","unstructured":"Lee J, Kim EH. Mechanisms underlying response and resistance to immune checkpoint blockade in cancer immunotherapy. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1233376.","journal-title":"Front Oncol"},{"issue":"2","key":"3396_CR95","doi-asserted-by":"publisher","first-page":"316","DOI":"10.17998\/jlc.2023.09.04","volume":"23","author":"YR Lee","year":"2023","unstructured":"Lee YR. A multidisciplinary approach with immunotherapies for advanced hepatocellular carcinoma. J Liver Cancer. 2023;23(2):316\u201329. https:\/\/doi.org\/10.17998\/jlc.2023.09.04.","journal-title":"J Liver Cancer"},{"issue":"1","key":"3396_CR96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41698-023-00443-3","volume":"7","author":"A Li","year":"2023","unstructured":"Li A, Luo L, Du W, Yu Z, He L, Fu S, et al. Deciphering transcriptomic determinants of the divergent link between PD-L1 and immunotherapy efficacy. NPJ Precis Oncol. 2023;7(1):87. https:\/\/doi.org\/10.1038\/s41698-023-00443-3.","journal-title":"NPJ Precis Oncol"},{"key":"3396_CR97","doi-asserted-by":"crossref","unstructured":"Li K, Wang J, Zhang R, Zhou J, Espinoza B, Niu N, Wang J, Jurcak NR, Rozich N, Osipov A, Henderson M, Funes V, Lyman MR, Blair AB, Herbst B, He M, Yuan J, Trafton D, Yuan C, Zheng L Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration. In J Hematol Oncol 2024; (Vol. 17) BioMed Central.","DOI":"10.1186\/s13045-024-01576-z"},{"issue":"11","key":"3396_CR98","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010534","volume":"12","author":"T Li","year":"2024","unstructured":"Li T, Guo S, Xu C, Zhang M, Lyu C, Xu H, et al. Integrated single-cell transcriptome and TCR profiles of hepatocellular carcinoma highlight the convergence on interferon signaling during immunotherapy. J Immunother Cancer. 2024;12(11):e010534. https:\/\/doi.org\/10.1136\/jitc-2024-010534.","journal-title":"J Immunother Cancer"},{"key":"3396_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1210673","author":"T Li","year":"2023","unstructured":"Li T, Qian X, Liu J, Feng X, Luo J, Yao G, et al. Radiotherapy plus immune checkpoint inhibitor in prostate cancer. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1210673.","journal-title":"Front Oncol"},{"key":"3396_CR100","doi-asserted-by":"publisher","first-page":"1643421","DOI":"10.3389\/fimmu.2025.1643421","volume":"16","author":"X Li","year":"2025","unstructured":"Li X, Gao S, Shan C, Zhang Q, Tan Y, Xu Y, et al. Advances in PD-1\/PD-L1 pathway inhibitors in the treatment of thyroid cancer: mechanisms and clinical therapeutic perspectives. Front Immunol. 2025;16:1643421\u20131643421. https:\/\/doi.org\/10.3389\/fimmu.2025.1643421.","journal-title":"Front Immunol"},{"key":"3396_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12163-3","author":"Y Li","year":"2024","unstructured":"Li Y, Chen Z, Tian S, Han X, Wang C, Wang Y, et al. Stereotactic ablative brachytherapy versus percutaneous microwave ablation as salvage treatments for lung oligometastasis from colorectal cancer. BMC Cancer. 2024. https:\/\/doi.org\/10.1186\/s12885-024-12163-3.","journal-title":"BMC Cancer"},{"key":"3396_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.965120","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Li X, Zhu L, Chen G-l, Xiang Z, Wang Q, et al. Clinical application status and prospect of the combined anti-tumor strategy of ablation and immunotherapy. Front Immunol. 2022;13:965120-965120. https:\/\/doi.org\/10.3389\/fimmu.2022.965120.","journal-title":"Front Immunol"},{"key":"3396_CR103","doi-asserted-by":"publisher","unstructured":"Ligero M, Gielen B, Navarro Vc, Morgado PC, Prior O, Dienstmann R, Nuc\u00edforo P, Trebeschi S, Beets\u2010Tan RGH, Sala E, Garralda E, P\u00e9rez-L\u00f3pez R A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking? npj Precision Oncology 2024; 8(1) https:\/\/doi.org\/10.1038\/s41698-024-00534-9","DOI":"10.1038\/s41698-024-00534-9"},{"key":"3396_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2024.1410017","author":"M Lin","year":"2024","unstructured":"Lin M, Kang Y, Zhang XF. Nanotechnology for the theranostic opportunity of breast cancer lung metastasis: recent advancements and future challenges. Front Bioeng Biotechnol. 2024. https:\/\/doi.org\/10.3389\/fbioe.2024.1410017.","journal-title":"Front Bioeng Biotechnol."},{"key":"3396_CR105","doi-asserted-by":"publisher","DOI":"10.1172\/jci148274","author":"TP Lippert","year":"2021","unstructured":"Lippert TP, Greenberg RA. The abscopal effect: a sense of DNA damage is in the air. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/jci148274.","journal-title":"J Clin Invest"},{"key":"3396_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1323070","author":"Q Liu","year":"2024","unstructured":"Liu Q, Zhang C, Chen X, Han Z. Modern cancer therapy: cryoablation meets immune checkpoint blockade [Review]. Front Oncol. 2024. https:\/\/doi.org\/10.3389\/fonc.2024.1323070.","journal-title":"Front Oncol"},{"key":"3396_CR107","doi-asserted-by":"publisher","unstructured":"Liu Q, Zhang Cy, Chen X, Han Z (2024b). Modern cancer therapy: cryoablation meets immune checkpoint blockade. Front Oncolo https:\/\/doi.org\/10.3389\/fonc.2024.1323070","DOI":"10.3389\/fonc.2024.1323070"},{"key":"3396_CR108","doi-asserted-by":"publisher","first-page":"1323070","DOI":"10.3389\/fonc.2024.1323070","volume":"14","author":"Q Liu","year":"2024","unstructured":"Liu Q, Zhang C, Chen X, Han Z. Modern cancer therapy: cryoablation meets immune checkpoint blockade. Front Oncol. 2024;14:1323070\u20131323070. https:\/\/doi.org\/10.3389\/fonc.2024.1323070.","journal-title":"Front Oncol"},{"key":"3396_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01430-8","author":"S Liu","year":"2023","unstructured":"Liu S, Sun Q, Ren X. Novel strategies for cancer immunotherapy: counter-immunoediting therapy. J Hematol Oncol. 2023. https:\/\/doi.org\/10.1186\/s13045-023-01430-8.","journal-title":"J Hematol Oncol."},{"issue":"1","key":"3396_CR110","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1186\/s12951-025-03695-2","volume":"23","author":"T Liu","year":"2025","unstructured":"Liu T, Yang L, Hou Y, Tian Y, Ashrafizadeh M, Orive G, et al. Programmable metal-based immuno-photocatalytic nanoparticles for precision activation of anti-tumor immunity. J Nanobiotechnol. 2025;23(1):671\u2013671. https:\/\/doi.org\/10.1186\/s12951-025-03695-2.","journal-title":"J Nanobiotechnol"},{"key":"3396_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1710803","author":"Y Liu","year":"2025","unstructured":"Liu Y, Pan L, Huang L, He Q, Zhang H, Gan J. Editorial: renewed insight into cancer mechanism and therapy. Front Oncology. 2025. https:\/\/doi.org\/10.3389\/fonc.2025.1710803.","journal-title":"Front Oncology."},{"issue":"12","key":"3396_CR112","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s11912-023-01473-7","volume":"25","author":"L Lukas","year":"2023","unstructured":"Lukas L, Zhang H, Cheng KKY, Epstein AL. Immune priming with spatially fractionated radiation therapy. Curr Oncol Rep. 2023;25(12):1483\u201396. https:\/\/doi.org\/10.1007\/s11912-023-01473-7.","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"3396_CR113","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3892\/ol.2024.14239","volume":"27","author":"F Ma","year":"2024","unstructured":"Ma F, Lin Y, Ni Z, Wang S, Zhang J, Wang X, et al. Microwave ablation enhances the systemic immune response in patients with lung cancer. Oncol Lett. 2024;27(3):106\u2013106. https:\/\/doi.org\/10.3892\/ol.2024.14239.","journal-title":"Oncol Lett"},{"issue":"1","key":"3396_CR114","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41420-024-02245-3","volume":"10","author":"X Ma","year":"2024","unstructured":"Ma X, Zhang W, Zeng M, Asavasupreechar T, Kang S, Li Y, et al. Systemic tumor regression with synergy therapy: radiotherapy and CAR-T. Cell Death Discov. 2024;10(1):479\u2013479. https:\/\/doi.org\/10.1038\/s41420-024-02245-3.","journal-title":"Cell Death Discov"},{"key":"3396_CR115","doi-asserted-by":"publisher","DOI":"10.2478\/aite-2024-0010","author":"D Mahajan","year":"2024","unstructured":"Mahajan D, Kumar T, Rath PK, Sahoo AK, Mishra BP, Kumar S, et al. Dendritic cells and the establishment of fetomaternal tolerance for successful human pregnancy. Arch Immunol et Ther Exp. 2024. https:\/\/doi.org\/10.2478\/aite-2024-0010.","journal-title":"Arch Immunol et Ther Exp."},{"key":"3396_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1268979","author":"H Mahdi","year":"2023","unstructured":"Mahdi H, Woodall-Jappe M, Singh P, Czuczman MS. Targeting regulatory T cells by E7777 enhances CD8 T-cell\u2013mediated anti-tumor activity and extends survival benefit of anti-PD-1 in solid tumor models. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1268979.","journal-title":"Front Immunol."},{"key":"3396_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-02902-0","author":"HE Marei","year":"2023","unstructured":"Marei HE, Hasan A, Pozzoli G, Cenciarelli C. Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired. Cancer Cell Int. 2023. https:\/\/doi.org\/10.1186\/s12935-023-02902-0.","journal-title":"Cancer Cell Int"},{"key":"3396_CR118","doi-asserted-by":"crossref","unstructured":"Mariam A, Kamath S, Schveder K, McLeod H, Rotroff D (2023). biomarkers for response to Anti\u2013PD-1\/Anti\u2013PD-L1 Immune Checkpoint Inhibitors: A Large Meta-Analysis. Oncology, 37, 210\u2013219. https:\/\/www.cancernetwork.com\/view\/print-biomarkers-for-response-to-anti-pd-1-anti-pd-l1-immune-checkpoint-inhibitors-a-large-meta-analysis (ONCOLOGY Vol 37, Issue 5)","DOI":"10.46883\/2023.25920995"},{"key":"3396_CR119","doi-asserted-by":"crossref","unstructured":"Marion J, Althouse AD (2023). The use of historical controls in clinical trials. In JAMA (Vol. 330, pp. 1484\u20131484): American Medical Association.","DOI":"10.1001\/jama.2023.16182"},{"issue":"1","key":"3396_CR120","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/02656736.2021.1887942","volume":"38","author":"A Markezana","year":"2021","unstructured":"Markezana A, Goldberg SN, Kumar G, Zorde-Khvalevsky E, Gourevtich S, Rozenblum N, et al. Incomplete thermal ablation of tumors promotes increased tumorigenesis. Int J Hyperthermia. 2021;38(1):263\u201372. https:\/\/doi.org\/10.1080\/02656736.2021.1887942.","journal-title":"Int J Hyperthermia"},{"key":"3396_CR121","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2022.03.013","volume":"84","author":"A Markou","year":"2022","unstructured":"Markou A, Tzanikou E, Lianidou E. The potential of liquid biopsy in the management of cancer patients. Semin Cancer Biol. 2022;84:69\u201379. https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.013.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"3396_CR122","doi-asserted-by":"publisher","first-page":"18229","DOI":"10.1038\/s41598-022-22279-w","volume":"12","author":"M Mauda-Havakuk","year":"2022","unstructured":"Mauda-Havakuk M, Hawken N, Owen J, Mikhail AS, Saxena A, Karim B, et al. Comparative analysis of the immune response to RFA and cryoablation in a colon cancer mouse model. Sci Rep. 2022;12(1):18229\u201318229. https:\/\/doi.org\/10.1038\/s41598-022-22279-w.","journal-title":"Sci Rep"},{"issue":"1","key":"3396_CR123","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41467-023-35948-9","volume":"14","author":"JM Mazet","year":"2023","unstructured":"Mazet JM, Mahale JN, Tong O, Watson R, Lechuga-Vieco AV, Pirgova G, et al. IFN\u03b3 signaling in cytotoxic T cells restricts anti-tumor responses by inhibiting the maintenance and diversity of intra-tumoral stem-like T cells. Nat Commun. 2023;14(1):321\u2013321. https:\/\/doi.org\/10.1038\/s41467-023-35948-9.","journal-title":"Nat Commun"},{"key":"3396_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1057535","author":"L Meng","year":"2023","unstructured":"Meng L, Wei Y, Xiao Y. Chemo-immunoablation of solid tumors: A new concept in tumor ablation. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2022.1057535.","journal-title":"Front Immunol."},{"key":"3396_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1111523","author":"W Mey","year":"2023","unstructured":"Mey W, Locy H, Ridder KD, Schrijver PD, Autaers D, Lakdimi A, et al. An mRNA mix redirects dendritic cells towards an antiviral program, inducing anticancer cytotoxic stem cell and central memory CD8+ T cells. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1111523.","journal-title":"Front Immunol"},{"issue":"23","key":"3396_CR126","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.3390\/cancers14235738","volume":"14","author":"J Miles","year":"2022","unstructured":"Miles J, Soubeyran I, Marliot F, Pangon N, Italiano A, Bellera C, et al. Determination of interactive states of immune checkpoint regulators in lung metastases after radiofrequency ablation. Cancers (Basel). 2022;14(23):5738\u20135738. https:\/\/doi.org\/10.3390\/cancers14235738.","journal-title":"Cancers (Basel)"},{"key":"3396_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1299064","author":"TA Mishchenko","year":"2024","unstructured":"Mishchenko TA, Turubanova VD, Gorshkova EN, Krysko O, Vedunova MV, Krysko DV. Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2023.1299064.","journal-title":"Front Immunol."},{"issue":"12","key":"3396_CR128","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1158\/2159-8290.Cd-21-0634","volume":"11","author":"EJ Moding","year":"2021","unstructured":"Moding EJ, Nabet BY, Alizadeh AA, Diehn M. Detecting liquid remnants of solid tumors: circulating tumor DNA minimal residual disease. Cancer Discov. 2021;11(12):2968\u201386. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-0634.","journal-title":"Cancer Discov"},{"key":"3396_CR129","doi-asserted-by":"publisher","unstructured":"Murphy P, Glynn D, Dias S, Hodgson R, Claxton L, Beresford L, Cooper K, Tappenden P, Ennis K, Grosso A, Wright K, Cantrell A, Stevenson M, Palmer S. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework. 25. 2021;76. https:\/\/doi.org\/10.3310\/hta25760","DOI":"10.3310\/hta25760"},{"issue":"2","key":"3396_CR130","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1158\/1078-0432.Ccr-23-1469","volume":"30","author":"JC Murray","year":"2024","unstructured":"Murray JC, Sivapalan L, Hummelink K, Balan A, White JR, Niknafs N, et al. Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer. Clin Cancer Res. 2024;30(2):389\u2013403. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-1469.","journal-title":"Clin Cancer Res"},{"key":"3396_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00792-x","author":"S Musunuri","year":"2024","unstructured":"Musunuri S, Weidenbacher PA, Kim PS. Bringing immunofocusing into focus. NPJ Vaccines. 2024. https:\/\/doi.org\/10.1038\/s41541-023-00792-x.","journal-title":"NPJ Vaccines"},{"key":"3396_CR132","doi-asserted-by":"publisher","DOI":"10.1186\/s42252-023-00050-2","author":"AH Negussie","year":"2024","unstructured":"Negussie AH, Morhard R, Rivera J, Delgado JF, Xu S, Wood BJ. Thermochromic phantoms and paint to characterize and model image-guided thermal ablation and ablation devices: a review. Funct Compos Mater. 2024. https:\/\/doi.org\/10.1186\/s42252-023-00050-2.","journal-title":"Funct Compos Mater."},{"issue":"4","key":"3396_CR133","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.medj.2023.02.003","volume":"4","author":"BE Nelson","year":"2023","unstructured":"Nelson BE, Adashek JJ, Lin SH, Subbiah V. The abscopal effect in patients with cancer receiving immunotherapy. Med (Baltimore). 2023;4(4):233\u201344. https:\/\/doi.org\/10.1016\/j.medj.2023.02.003.","journal-title":"Med (Baltimore)"},{"issue":"6","key":"3396_CR134","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1158\/1535-7163.mct-22-0516","volume":"22","author":"BE Nelson","year":"2023","unstructured":"Nelson BE, Adashek JJ, Sheth AA, Subbiah V. Predicting the abscopal effect: associated tumor histologic subtypes and biomarkers. Mol Cancer Ther. 2023;22(6):706\u201316. https:\/\/doi.org\/10.1158\/1535-7163.mct-22-0516.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"3396_CR135","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2023.2263672","volume":"40","author":"T Osada","year":"2023","unstructured":"Osada T, Jiang X, Zhao Y, Chen M, Kreager BC, Wu H, et al. The use of histotripsy as intratumoral immunotherapy beyond tissue ablation\u2014the rationale for exploring the immune effects of histotripsy. Int J Hyperthermia. 2023;40(1):2263672. https:\/\/doi.org\/10.1080\/02656736.2023.2263672.","journal-title":"Int J Hyperthermia"},{"key":"3396_CR136","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2023.12209","author":"Y Oshiro","year":"2023","unstructured":"Oshiro Y, Mizumoto M, Hisanaga T, Tanaka K, Komine M, Takahashi M, et al. Abscopal effect with fever of unknown cause during radiotherapy: two case reports and review of the literature. Exp Therapeutic Med. 2023. https:\/\/doi.org\/10.3892\/etm.2023.12209.","journal-title":"Exp Therapeutic Med."},{"key":"3396_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36045-7","author":"W Ou","year":"2023","unstructured":"Ou W, Stewart S, White A, Kwizera EA, Xu J, Fang Y, et al. In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy. Nat Commun. 2023. https:\/\/doi.org\/10.1038\/s41467-023-36045-7.","journal-title":"Nat Commun."},{"issue":"12","key":"3396_CR138","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.1039\/D1CS01148K","volume":"51","author":"J Ouyang","year":"2022","unstructured":"Ouyang J, Xie A, Zhou J, Liu R, Wang L, Liu H, et al. Minimally invasive nanomedicine: nanotechnology in photo-\/ultrasound-\/radiation-\/magnetism-mediated therapy and imaging. Chem Soc Rev. 2022;51(12):4996\u20135041. https:\/\/doi.org\/10.1039\/D1CS01148K.","journal-title":"Chem Soc Rev"},{"issue":"9","key":"3396_CR139","doi-asserted-by":"publisher","first-page":"7979","DOI":"10.1021\/acsnano.3c00891","volume":"17","author":"M Overchuk","year":"2023","unstructured":"Overchuk M, Weersink RA, Wilson BC, Zheng G. Photodynamic and photothermal therapies: synergy opportunities for nanomedicine. ACS Nano. 2023;17(9):7979\u20138003. https:\/\/doi.org\/10.1021\/acsnano.3c00891.","journal-title":"ACS Nano"},{"key":"3396_CR140","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1677548","volume":"16","author":"MFM Pacheco","year":"2025","unstructured":"Pacheco MFM, Tai LH. Reprogramming the tumor microenvironment to boost adoptive T cell therapy. Front Immunol. 2025;16:1677548. https:\/\/doi.org\/10.3389\/fimmu.2025.1677548.","journal-title":"Front Immunol"},{"issue":"4","key":"3396_CR141","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.medj.2024.01.015","volume":"5","author":"H Pan","year":"2024","unstructured":"Pan H, Yu M, Tang X, Mao X, Liu M, Zhang K, et al. Preoperative single-dose camrelizumab and\/or microwave ablation in women with early-stage breast cancer: a window-of-opportunity trial. Med. 2024;5(4):291-310.e295. https:\/\/doi.org\/10.1016\/j.medj.2024.01.015.","journal-title":"Med"},{"key":"3396_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1196829","author":"E Papaevangelou","year":"2023","unstructured":"Papaevangelou E, Esteves AM, Dasgupta P, Galustian C. Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1196829.","journal-title":"Front Immunol."},{"issue":"1","key":"3396_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s42004-025-01705-w","volume":"8","author":"C Patnaik","year":"2025","unstructured":"Patnaik C, Rath S, De A. Avenues for integrating photothermal therapy in cancer clinic. Commun Chem. 2025;8(1):324. https:\/\/doi.org\/10.1038\/s42004-025-01705-w.","journal-title":"Commun Chem"},{"key":"3396_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1335987","author":"EF Patz","year":"2024","unstructured":"Patz EF, Gottlin EB, Simon GR. Perspective: rethinking therapeutic strategies in oncology. Front Oncol. 2024. https:\/\/doi.org\/10.3389\/fonc.2023.1335987.","journal-title":"Front Oncol"},{"key":"3396_CR145","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s457782","author":"J Peng","year":"2024","unstructured":"Peng J, Li S, Ti H. Sensitize tumor immunotherapy: immunogenic cell death inducing nanosystems. Int J Nanomedicine. 2024. https:\/\/doi.org\/10.2147\/ijn.s457782.","journal-title":"Int J Nanomedicine"},{"key":"3396_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1012799","author":"A Pepple","year":"2023","unstructured":"Pepple A, Guy JL, McGinnis R, Felsted AE, Song BJ, Hubbard R, et al. Spatiotemporal local and abscopal cell death and immune responses to histotripsy focused ultrasound tumor ablation. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1012799.","journal-title":"Front Immunol."},{"issue":"1","key":"3396_CR147","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1080\/02656736.2021.1991012","volume":"39","author":"A Pfannenstiel","year":"2022","unstructured":"Pfannenstiel A, Iannuccilli J, Cornelis FH, Dupuy DE, Beard WL, Prakash P. Shaping the future of microwave tumor ablation: a new direction in precision and control of device performance. Int J Hyperthermia. 2022;39(1):664\u201374. https:\/\/doi.org\/10.1080\/02656736.2021.1991012.","journal-title":"Int J Hyperthermia"},{"issue":"5","key":"3396_CR148","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","volume":"20","author":"AD Prete","year":"2023","unstructured":"Prete AD, Salvi V, Soriani A, Laffranchi M, Sozio F, Bosisio D, et al. Dendritic cell subsets in cancer immunity and tumor antigen sensing. Cell Mol Immunol. 2023;20(5):432\u201347. https:\/\/doi.org\/10.1038\/s41423-023-00990-6.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"3396_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02393-7","volume":"4","author":"M Przedborski","year":"2021","unstructured":"Przedborski M, Smalley M, Thiyagarajan S, Goldman A, Kohandel M. Systems biology informed neural networks (SBINN) predict response and novel combinations for PD-1 checkpoint blockade. Commun Biol. 2021;4(1):877. https:\/\/doi.org\/10.1038\/s42003-021-02393-7.","journal-title":"Commun Biol"},{"key":"3396_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1325946","author":"D Qin","year":"2024","unstructured":"Qin D, Zhang Y, Shu P, Lei Y, Li X, Wang Y. Targeting tumor-infiltrating tregs for improved antitumor responses. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1325946.","journal-title":"Front Immunol."},{"key":"3396_CR151","doi-asserted-by":"publisher","first-page":"1621812","DOI":"10.3389\/fimmu.2025.1621812","volume":"16","author":"KJ Racacho","year":"2025","unstructured":"Racacho KJ, Shiau YP, Villa R, Mahri S, Tang M, Lin YT, et al. The tumor immune microenvironment: implications for cancer immunotherapy, treatment strategies, and monitoring approaches. Front Immunol. 2025;16:1621812\u20131621812.","journal-title":"Front Immunol."},{"issue":"1","key":"3396_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03802-x","volume":"12","author":"A Radosevic","year":"2022","unstructured":"Radosevic A, Quesada R, Serlavos C, S\u00e1nchez J, Zugazaga A, Sierra A, et al. Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial. Sci Rep. 2022;12(1):316. https:\/\/doi.org\/10.1038\/s41598-021-03802-x.","journal-title":"Sci Rep"},{"key":"3396_CR153","doi-asserted-by":"publisher","DOI":"10.1186\/s41181-024-00266-y","author":"RM Reilly","year":"2024","unstructured":"Reilly RM, Georgiou CJ, Brown MK, Cai Z. Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape. EJNMMI Radiopharm Chem. 2024. https:\/\/doi.org\/10.1186\/s41181-024-00266-y.","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"4","key":"3396_CR154","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3390\/cancers15041200","volume":"15","author":"TP Robinson","year":"2023","unstructured":"Robinson TP, Pebror T, Krosin M, Koniaris LG. Ablative therapy in non-HCC liver malignancy. Cancers (Basel). 2023;15(4):1200\u20131200. https:\/\/doi.org\/10.3390\/cancers15041200.","journal-title":"Cancers (Basel)"},{"key":"3396_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.prnil.2025.07.002","author":"R Rold\u00e1n-Testillano","year":"2025","unstructured":"Rold\u00e1n-Testillano R, Rodr\u00edguez-S\u00e1nchez L, Covarrubias C, Durazo-Ruiz FO, Arezki A, Anidjar M, et al. Advances in focal therapy for prostate cancer: current modalities, outcomes, and future directions. Prostate Int. 2025. https:\/\/doi.org\/10.1016\/j.prnil.2025.07.002.","journal-title":"Prostate Int"},{"key":"3396_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104903","author":"A Rossi","year":"2025","unstructured":"Rossi A, Muratori C. Physical ablative methods and cancer cell death: implications for immunity and therapies. Critical Rev Oncology\/Hematology. 2025. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104903.","journal-title":"Critical Rev Oncology\/Hematology."},{"key":"3396_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1264327","author":"D Roy","year":"2023","unstructured":"Roy D, Gilmour C, Patnaik S, Wang LL. Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1264327.","journal-title":"Front Immunol"},{"issue":"1","key":"3396_CR158","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1038\/s41467-023-40844-3","volume":"14","author":"N-P Rudqvist","year":"2023","unstructured":"Rudqvist N-P, Charpentier M, Lhuillier C, Wennerberg E, Spada S, Sheridan C, et al. Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors. Nat Commun. 2023;14(1):5146\u20135146. https:\/\/doi.org\/10.1038\/s41467-023-40844-3.","journal-title":"Nat Commun"},{"issue":"6","key":"3396_CR159","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1158\/2159-8290.Cd-20-1312","volume":"11","author":"D Salas-Benito","year":"2021","unstructured":"Salas-Benito D, P\u00e9rez-Gracia JL, Ponz-Sarvis\u00e9 M, Rodriguez-Ruiz ME, Mart\u00ednez-Forero I, Casta\u00f1\u00f3n E, et al. Paradigms on immunotherapy combinations with chemotherapy. Cancer Discov. 2021;11(6):1353\u201367. https:\/\/doi.org\/10.1158\/2159-8290.Cd-20-1312.","journal-title":"Cancer Discov"},{"key":"3396_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1268331","author":"J Sang","year":"2023","unstructured":"Sang J, Ye X. Potential biomarkers for predicting immune response and outcomes in lung cancer patients undergoing thermal ablation. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1268331.","journal-title":"Front Immunol."},{"issue":"1","key":"3396_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-025-00873-1","volume":"12","author":"A Sanjari Moghaddam","year":"2025","unstructured":"Sanjari Moghaddam A, Lu KY, Nasrollahi E, Oji L, Homeniuk A, Amosu O, et al. Biomarker prediction of immunotherapy response in breast cancer: from single markers to multi-omics integration. npj Breast Cancer. 2025;12(1):10. https:\/\/doi.org\/10.1038\/s41523-025-00873-1.","journal-title":"npj Breast Cancer"},{"issue":"2","key":"3396_CR162","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s12072-023-10537-6","volume":"18","author":"S Santagata","year":"2023","unstructured":"Santagata S, Rea G, Castaldo D, Napolitano M, Capiluongo A, D\u2019Alterio C, et al. Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment. Hepatol Int. 2023;18(2):568\u201381. https:\/\/doi.org\/10.1007\/s12072-023-10537-6.","journal-title":"Hepatol Int"},{"key":"3396_CR163","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2025.1646659","author":"KM Santifort","year":"2025","unstructured":"Santifort KM, Gutierrez-Quintana R, Olby NJ, Meij BP, Aige-Gil V, Matiasek K, et al. The value of case reports. Front Veterinary Sci. 2025. https:\/\/doi.org\/10.3389\/fvets.2025.1646659.","journal-title":"Front Veterinary Sci."},{"issue":"4","key":"3396_CR164","doi-asserted-by":"publisher","first-page":"eabi8618","DOI":"10.1126\/sciadv.abi8618","volume":"8","author":"E Sanz-Garcia","year":"2022","unstructured":"Sanz-Garcia E, Zhao E, Bratman SV, Siu LL. Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: current research, opportunities, and challenges. Sci Adv. 2022;8(4):eabi8618. https:\/\/doi.org\/10.1126\/sciadv.abi8618","journal-title":"Sci Adv"},{"key":"3396_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1258873","author":"F Sardela de Miranda","year":"2023","unstructured":"Sardela de Miranda F, Castro M, Remmert N, Singh SP, Layeequr Rahman R, Melkus MW. Leveraging cryoablation and checkpoint inhibitors for high-risk triple negative breast cancer [Mini Review]. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1258873.","journal-title":"Front Immunol."},{"key":"3396_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(22)00742-2","author":"L Shankar","year":"2023","unstructured":"Shankar L, Sch\u00f6der H, Sharon E, Wolchok JD, Knopp MV, Wahl RL, et al. Harnessing imaging tools to guide immunotherapy trials: summary from the national cancer institute cancer imaging steering committee workshop. The Lancet Oncol. 2023. https:\/\/doi.org\/10.1016\/s1470-2045(22)00742-2.","journal-title":"The Lancet Oncol."},{"issue":"6","key":"3396_CR167","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.euf.2025.06.007","volume":"11","author":"K Shee","year":"2025","unstructured":"Shee K, Pace WA, Liu AW, Cowan JE, Subramanyam V, Agapito C, et al. Determining optimal patient selection for high-intensity focused ultrasound for prostate cancer. Eur Urol Focus. 2025;11(6):869\u201375. https:\/\/doi.org\/10.1016\/j.euf.2025.06.007.","journal-title":"Eur Urol Focus"},{"key":"3396_CR168","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1073681","author":"H Shen","year":"2023","unstructured":"Shen H, Wang L, Zhang Y, Huang G, Liu B. Knowledge mapping of image-guided tumor ablation and immunity: a bibliometric analysis. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1073681.","journal-title":"Front Immunol"},{"key":"3396_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1073681","volume":"14","author":"H Shen","year":"2023","unstructured":"Shen H, Wang L, Zhang Y, Huang G, Liu B. Knowledge mapping of image-guided tumor ablation and immunity: a bibliometric analysis. Front Immunol. 2023;14:1073681. https:\/\/doi.org\/10.3389\/fimmu.2023.1073681.","journal-title":"Front Immunol"},{"key":"3396_CR170","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-024-03637-1","author":"L Shen","year":"2024","unstructured":"Shen L, Tan H, Nie J, Jiang Y, Nuerhashi G, Qi H, et al. Size selection of intrahepatic lesions for cryoablation contributes to abscopal effect and long-term survival in patients with liver metastatic melanoma receiving PD-1 blockade therapy. Cancer Immunol Immunotherapy. 2024. https:\/\/doi.org\/10.1007\/s00262-024-03637-1.","journal-title":"Cancer Immunol Immunotherapy."},{"issue":"2","key":"3396_CR171","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/15368378.2020.1741383","volume":"39","author":"S Singh","year":"2020","unstructured":"Singh S, Melnik R. Thermal ablation of biological tissues in disease treatment: a review of computational models and future directions. Electromagn Biol Med. 2020;39(2):49\u201388. https:\/\/doi.org\/10.1080\/15368378.2020.1741383.","journal-title":"Electromagn Biol Med"},{"issue":"1","key":"3396_CR172","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005924","volume":"11","author":"L Sivapalan","year":"2023","unstructured":"Sivapalan L, Murray JC, Canzoniero JV, Landon B, Jackson J, Scott S, et al. Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy. J Immunother Cancer. 2023;11(1):e005924. https:\/\/doi.org\/10.1136\/jitc-2022-005924.","journal-title":"J Immunother Cancer"},{"key":"3396_CR173","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1650760","author":"B Song","year":"2025","unstructured":"Song B, Guo W, He Y, Yao X, Sun J, Wang S. Targeting immune cell migration as therapy for inflammatory disease: a review [Review]. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1650760.","journal-title":"Front Immunol."},{"key":"3396_CR174","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2024.255","author":"CW Song","year":"2024","unstructured":"Song CW, Kim H, Kim M, Park HJ, Paek S-H, Terezakis SA, et al. Role of HIF-1\u03b1 in the responses of tumors to radiotherapy and chemotherapy. Cancer Res Treat. 2024. https:\/\/doi.org\/10.4143\/crt.2024.255.","journal-title":"Cancer Res Treat"},{"key":"3396_CR175","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02311-z","author":"Z Sun","year":"2024","unstructured":"Sun Z, Zhao H, Ma L, Shi Y, Ji M, Sun X, et al. The quest for nanoparticle-powered vaccines in cancer immunotherapy. J Nanobiotechnol. 2024. https:\/\/doi.org\/10.1186\/s12951-024-02311-z.","journal-title":"J Nanobiotechnol."},{"issue":"1","key":"3396_CR176","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-025-02955-4","volume":"14","author":"MJJ Taha","year":"2025","unstructured":"Taha MJJ, Abuawwad MT. Integrating case reports into systematic reviews: methodological strategies and challenges. Syst Rev. 2025;14(1):208. https:\/\/doi.org\/10.1186\/s13643-025-02955-4.","journal-title":"Syst Rev"},{"issue":"2","key":"3396_CR177","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41590-023-01722-8","volume":"25","author":"M Takahama","year":"2024","unstructured":"Takahama M, Patil A, Richey G, Cipurko D, Johnson K, Carbonetto P, et al. A pairwise cytokine code explains the organism-wide response to sepsis. Nat Immunol. 2024;25(2):226\u201339. https:\/\/doi.org\/10.1038\/s41590-023-01722-8.","journal-title":"Nat Immunol"},{"key":"3396_CR178","first-page":"33","volume":"7","author":"L Tang","year":"2024","unstructured":"Tang L, Wang D, Hu T, Lin X, Wu S. Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment. Cancer Drug Res. 2024;7:33\u201333.","journal-title":"Cancer Drug Res."},{"key":"3396_CR179","doi-asserted-by":"publisher","first-page":"1667812","DOI":"10.3389\/fphar.2025.1667812","volume":"16","author":"J Tao","year":"2025","unstructured":"Tao J, Yuan Z, Zhou M. Targeted photodynamic therapy: enhancing efficacy through specific organelle engagement. Front Pharmacol. 2025;16:1667812\u20131667812. https:\/\/doi.org\/10.3389\/fphar.2025.1667812.","journal-title":"Front Pharmacol"},{"key":"3396_CR180","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1375767","author":"J Thiruppathi","year":"2024","unstructured":"Thiruppathi J, Vijayan V, Park IK, Lee SE, Rhee JH. Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1375767.","journal-title":"Front Immunol"},{"key":"3396_CR181","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.708810","volume":"11","author":"KG Tranberg","year":"2021","unstructured":"Tranberg KG. Local destruction of tumors and systemic immune effects. Front Oncol. 2021;11:708810. https:\/\/doi.org\/10.3389\/fonc.2021.708810.","journal-title":"Front Oncol"},{"key":"3396_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02280-1","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang C, Li N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduct Target Therapy. 2025. https:\/\/doi.org\/10.1038\/s41392-025-02280-1.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"3396_CR183","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev-chembioeng-082223-054259","volume":"16","author":"J Vallin","year":"2025","unstructured":"Vallin J, Azarin SM. Leveraging the immunological impacts of irreversible electroporation as a new frontier for cancer therapy. Annu Rev Chem Biomol Eng. 2025;16(1):169\u201393. https:\/\/doi.org\/10.1146\/annurev-chembioeng-082223-054259.","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"3396_CR184","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1682306","volume":"16","author":"R Vella","year":"2025","unstructured":"Vella R, Panci D, Carini F, Malta G, Vieni S, David S, et al. Cytokines in sepsis: a critical review of the literature on systemic inflammation and multiple organ dysfunction. Front Immunol. 2025;16:1682306. https:\/\/doi.org\/10.3389\/fimmu.2025.1682306.","journal-title":"Front Immunol"},{"key":"3396_CR185","doi-asserted-by":"publisher","unstructured":"Versluis JM, Blankenstein SA, Dimitriadis P, Wilmott JS, Elens R, Blokx WAM, Houdt WJv, Menzies AM, Schrage Y, Wouters MWJM, Sanders J, Broeks A, Scolyer RA, Suijkerbuijk KPM, Long GV, Akkooi ACJv, Blank CU Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma. J ImmunoTherapy of Cancer. 2024; https:\/\/doi.org\/10.1136\/jitc-2023-008125","DOI":"10.1136\/jitc-2023-008125"},{"key":"3396_CR186","doi-asserted-by":"publisher","unstructured":"Viborg N, Pavlidis MA, Barrio-Calvo M, Friis S, Trolle T, Sorensen AB, Thygesen CB, Kofoed, SV, Kleine\u2010Kohlbrecher D, Hadrup SR, R\u00f8n\u00f8, B DNA based neoepitope vaccination induces tumor control in syngeneic mouse models. npj Vaccines. 2023; 8 1 https:\/\/doi.org\/10.1038\/s41541-023-00671-5","DOI":"10.1038\/s41541-023-00671-5"},{"issue":"10","key":"3396_CR187","doi-asserted-by":"publisher","first-page":"8236","DOI":"10.1021\/acsnano.5c10858","volume":"20","author":"B Wang","year":"2026","unstructured":"Wang B, Yan Z, Shen Y, Fan S, Wang S, Wang W, et al. Reprogramming postablation tumor immune microenvironment with dual-function nanotherapeutic immunomodulator for synergistic antitumor immunity and recurrence suppression. ACS Nano. 2026;20(10):8236\u201354. https:\/\/doi.org\/10.1021\/acsnano.5c10858.","journal-title":"ACS Nano"},{"issue":"14","key":"3396_CR188","doi-asserted-by":"publisher","first-page":"13278","DOI":"10.1021\/acsnano.3c00941","volume":"17","author":"D Wang","year":"2023","unstructured":"Wang D, Yu Z, Qi Y, Hu K, Zhou T, Liu J, et al. Liquid metal nanoplatform based autologous cancer vaccines. ACS Nano. 2023;17(14):13278\u201395. https:\/\/doi.org\/10.1021\/acsnano.3c00941.","journal-title":"ACS Nano"},{"key":"3396_CR189","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.792781","author":"K Wang","year":"2021","unstructured":"Wang K, Wang C, Jiang H, Zhang Y, Lin W, Mo J, et al. Combination of ablation and immunotherapy for hepatocellular carcinoma: where we are and where to go [Review]. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.792781.","journal-title":"Front Immunol"},{"key":"3396_CR190","doi-asserted-by":"publisher","first-page":"792781","DOI":"10.3389\/fimmu.2021.792781","volume":"12","author":"K Wang","year":"2021","unstructured":"Wang K, Wang C, Jiang H, Zhang Y, Lin W, Mo J, et al. Combination of ablation and immunotherapy for hepatocellular carcinoma: where we are and where to go. Front Immunol. 2021;12:792781\u2013792781. https:\/\/doi.org\/10.3389\/fimmu.2021.792781.","journal-title":"Front Immunol"},{"key":"3396_CR191","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232101","author":"L Wang","year":"2024","unstructured":"Wang L, Lynch C, Pitroda SP, Piffk\u00f3 A, Yang K, Huser AK, et al. Radiotherapy and immunology. The J Exp Med. 2024. https:\/\/doi.org\/10.1084\/jem.20232101.","journal-title":"The J Exp Med."},{"key":"3396_CR192","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1146195","author":"M Wang","year":"2023","unstructured":"Wang M, Duan Y, Yang M, Guo Y, Li F, Wang J, et al. The analysis of immunogenic cell death induced by ablation at different temperatures in hepatocellular carcinoma cells. Front Cell Dev Biol. 2023. https:\/\/doi.org\/10.3389\/fcell.2023.1146195.","journal-title":"Front Cell Dev Biol"},{"key":"3396_CR193","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1754669","author":"X Wang","year":"2026","unstructured":"Wang X, Dong J, Fang S, Zhou Y, Cao R, Cheng X, et al. Reframing the paradigm: stereotactic body radiation therapy as an engineer of the tumor immune microenvironment [Review]. Front Immunol. 2026. https:\/\/doi.org\/10.3389\/fimmu.2026.1754669.","journal-title":"Front Immunol."},{"issue":"31","key":"3396_CR194","doi-asserted-by":"publisher","first-page":"12234","DOI":"10.1039\/d3sc07006a","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Peng J, Meng C, Feng F. Recent advances for enhanced photodynamic therapy: from new mechanisms to innovative strategies. Chem Sci. 2024;15(31):12234\u201357. https:\/\/doi.org\/10.1039\/d3sc07006a.","journal-title":"Chem Sci"},{"key":"3396_CR195","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1357101","author":"X Wang","year":"2024","unstructured":"Wang X, Wang Y, Zhang Y, Shi H, Liu K, Wang F, et al. Immune modulatory roles of radioimmunotherapy: biological principles and clinical prospects. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1357101.","journal-title":"Front Immunol"},{"key":"3396_CR196","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1357101","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Wang Y, Zhang Y, Shi H, Liu K, Wang F, et al. Immune modulatory roles of radioimmunotherapy: biological principles and clinical prospects. Front Immunol. 2024;15:1357101. https:\/\/doi.org\/10.3389\/fimmu.2024.1357101.","journal-title":"Front Immunol"},{"key":"3396_CR197","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1732079","author":"X Wang","year":"2026","unstructured":"Wang X, Xiong D, Cui S, Duan B, Ding G, Huang Y, et al. Artificial intelligence\u2013enabled multi-omics biomarkers for immune checkpoint blockade: mechanisms, predictive modeling, and clinical translation [Review]. Front Immunol. 2026. https:\/\/doi.org\/10.3389\/fimmu.2026.1732079.","journal-title":"Front Immunol."},{"key":"3396_CR198","doi-asserted-by":"publisher","DOI":"10.1007\/s40820-024-01557-4","author":"X Wang","year":"2024","unstructured":"Wang X, Zeng J, Gan D, Ling K, He M, Li J, et al. Recent strategies and advances in hydrogel-based delivery platforms for bone regeneration. Nano-Micro Letters. 2024. https:\/\/doi.org\/10.1007\/s40820-024-01557-4.","journal-title":"Nano-Micro Letters"},{"issue":"1","key":"3396_CR199","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40364-024-00628-3","volume":"12","author":"X Wang","year":"2024","unstructured":"Wang X, Zhang H, XinZhang, & Liu, Y. Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy. Biomark Res. 2024;12(1):98\u201398.","journal-title":"Biomark Res."},{"key":"3396_CR200","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.683419","author":"Y Wang","year":"2021","unstructured":"Wang Y, Tong Z, Zhang W, Zhang W, Buzdin A, Mu X, et al. FDA-Approved and emerging next generation predictive biomarkers for immune checkpoint Inhi bitors in cancer patients [Review]. Front Oncol. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.683419.","journal-title":"Front Oncol."},{"key":"3396_CR201","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1160932","author":"Z Wei","year":"2023","unstructured":"Wei Z, Iezzi R, Ye X. Editorial: local ablative therapies for the management of lung cancer. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1160932.","journal-title":"Front Oncol."},{"issue":"5","key":"3396_CR202","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s12094-023-03337-9","volume":"26","author":"H Weishan","year":"2023","unstructured":"Weishan H, Dong-lin Z, Guangmei D, Liu W, Wu F, Chen J. Immunoradiotherapy for NSCLC: mechanisms, clinical outcomes, and future directions. Clin Transl Oncol. 2023;26(5):1063\u201376. https:\/\/doi.org\/10.1007\/s12094-023-03337-9.","journal-title":"Clin Transl Oncol"},{"issue":"10","key":"3396_CR203","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/s41588-023-01499-4","volume":"55","author":"PMK Westcott","year":"2023","unstructured":"Westcott PMK, Muyas F, Hauck H, Smith O, Sacks N, Ely ZA, et al. Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity. Nat Genet. 2023;55(10):1686\u201395. https:\/\/doi.org\/10.1038\/s41588-023-01499-4.","journal-title":"Nat Genet"},{"issue":"10","key":"3396_CR204","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.746","volume":"5","author":"J Wu","year":"2024","unstructured":"Wu J, Zhou Z, Huang Y, Deng X, Zheng S, He S, et al. Radiofrequency ablation: mechanisms and clinical applications. MedComm. 2024;5(10):e746. https:\/\/doi.org\/10.1002\/mco2.746.","journal-title":"MedComm"},{"key":"3396_CR205","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1169608","author":"Q Wu","year":"2023","unstructured":"Wu Q, Xia Y, Xiong X, Duan X, Pang X, Zhang F, et al. Focused ultrasound-mediated small-molecule delivery to potentiate immune checkpoint blockade in solid tumors. Front Pharmacol. 2023. https:\/\/doi.org\/10.3389\/fphar.2023.1169608.","journal-title":"Front Pharmacol."},{"key":"3396_CR206","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1618903","author":"R Xia","year":"2025","unstructured":"Xia R, Liang J, Ma J, Du X, Ma L, Han X, et al. Research advances in immune agonists and their nanoparticles for enhancing the immunotherapeutic efficacy of PD-1 inhibitors in malignancies. Front Oncol. 2025. https:\/\/doi.org\/10.3389\/fonc.2025.1618903.","journal-title":"Front Oncol."},{"key":"3396_CR207","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1457368","author":"Y Xiao","year":"2024","unstructured":"Xiao Y. Editorial: community series in tumor ablation and immunity, volume II. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1457368.","journal-title":"Front Immunol."},{"issue":"1","key":"3396_CR208","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12893-025-02778-z","volume":"25","author":"G-L Xie","year":"2025","unstructured":"Xie G-L, Zhong Z-H, Ye T-W, Xiao Z-Q. Radiofrequency ablation combined with immunotherapy to treat hepatocellular carcinoma: a comprehensive review. BMC Surg. 2025;25(1):47. https:\/\/doi.org\/10.1186\/s12893-025-02778-z.","journal-title":"BMC Surg"},{"issue":"4","key":"3396_CR209","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.ymthe.2023.01.017","volume":"31","author":"L Xie","year":"2023","unstructured":"Xie L, Meng Z. Immunomodulatory effect of locoregional therapy in the tumor microenvironment. Mol Ther. 2023;31(4):951\u201369. https:\/\/doi.org\/10.1016\/j.ymthe.2023.01.017.","journal-title":"Mol Ther"},{"key":"3396_CR210","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1392495","author":"Y Xie","year":"2024","unstructured":"Xie Y, Lyu T, Guan H, Cao S, Song L, Tong X, et al. Radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinoma meeting Milan criteria: a focus on tumor progression and recurrence patterns. Fronti Oncol. 2024. https:\/\/doi.org\/10.3389\/fonc.2024.1392495.","journal-title":"Fronti Oncol."},{"issue":"8","key":"3396_CR211","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41589-023-01529-6","volume":"20","author":"D Xu","year":"2024","unstructured":"Xu D, Carter J, Li C, Utz A, Weidenbacher PA, Tang S, et al. Vaccine design via antigen reorientation. Nat Chem Biol. 2024;20(8):1012\u201321. https:\/\/doi.org\/10.1038\/s41589-023-01529-6.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"3396_CR212","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41467-025-55876-0","volume":"16","author":"J Xu","year":"2025","unstructured":"Xu J, Li Z, Tong Q, Zhang S, Fang J, Wu A, et al. CD133+PD-L1+ cancer cells confer resistance to adoptively transferred engineered macrophage-based therapy in melanoma. Nat Commun. 2025;16(1):895\u2013895. https:\/\/doi.org\/10.1038\/s41467-025-55876-0.","journal-title":"Nat Commun"},{"issue":"1","key":"3396_CR213","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-022-01307-2","volume":"15","author":"L Xu","year":"2022","unstructured":"Xu L, Zou C, Zhang S, Chu TSM, Zhang Y, Chen W, et al. Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors. J Hematol Oncol. 2022;15(1):87\u201387. https:\/\/doi.org\/10.1186\/s13045-022-01307-2.","journal-title":"J Hematol Oncol"},{"key":"3396_CR214","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1228910","author":"Y Xu","year":"2023","unstructured":"Xu Y, Jiang D, Chen W. Editorial: tumor microenvironment targeted nanomedicine: a feasible strategy for cancer imaging and theranostics. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1228910.","journal-title":"Front Oncol."},{"issue":"1","key":"3396_CR215","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-025-01676-1","volume":"25","author":"F Yang","year":"2025","unstructured":"Yang F, Shaibu Z, Liu Q, Zhu W. Cytokine profiles as predictive biomarkers for treatment outcomes in advanced gastric cancer patients undergoing PD-1 blockade immunochemotherapy: a meta-analysis. Clin Exp Med. 2025;25(1):136. https:\/\/doi.org\/10.1007\/s10238-025-01676-1.","journal-title":"Clin Exp Med"},{"key":"3396_CR216","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.969447","volume":"13","author":"X Yang","year":"2022","unstructured":"Yang X, Gao M, Xu R, Tao Y, Wang L, Wang B, et al. Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors. Front Immunol. 2022;13:969447. https:\/\/doi.org\/10.3389\/fimmu.2022.969447.","journal-title":"Front Immunol"},{"key":"3396_CR217","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306595","author":"X Yang","year":"2024","unstructured":"Yang X, Liao Y, Fan L, Lin B, Li J, Wu D, et al. High-intensity focused ultrasound ablation combined with immunotherapy for treating liver metastases: a prospective non-randomized trial. PLoS ONE. 2024. https:\/\/doi.org\/10.1371\/journal.pone.0306595.","journal-title":"PLoS ONE"},{"issue":"1","key":"3396_CR218","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1038\/s41467-021-24604-9","volume":"12","author":"Z Yang","year":"2021","unstructured":"Yang Z, Zhu Y, Dong Z, Li W, Yang N, Wang X, et al. Tumor-killing nanoreactors fueled by tumor debris can enhance radiofrequency ablation therapy and boost antitumor immune responses. Nat Commun. 2021;12(1):4299\u20134299. https:\/\/doi.org\/10.1038\/s41467-021-24604-9.","journal-title":"Nat Commun"},{"key":"3396_CR219","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-024-03632-6","author":"X Ye","year":"2024","unstructured":"Ye X, Yu Y, Zheng X, Ma H. Clinical immunotherapy in pancreatic cancer. Cancer Immunol Immunother. 2024. https:\/\/doi.org\/10.1007\/s00262-024-03632-6.","journal-title":"Cancer Immunol Immunother"},{"key":"3396_CR220","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01885-w","author":"M Yi","year":"2023","unstructured":"Yi M, Li T, Niu M, Mei Q, Zhao B, Chu Q, et al. Exploiting innate immunity for cancer immunotherapy. Mol Cancer. 2023. https:\/\/doi.org\/10.1186\/s12943-023-01885-w.","journal-title":"Mol Cancer."},{"key":"3396_CR221","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01826-z","author":"N Yin","year":"2024","unstructured":"Yin N, Li X, Zhang X, Xue S, Cao Y, Niedermann G, et al. Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities. Signal Transduc Target Ther. 2024. https:\/\/doi.org\/10.1038\/s41392-024-01826-z.","journal-title":"Signal Transduc Target Ther"},{"key":"3396_CR222","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1483454","author":"X Yin","year":"2024","unstructured":"Yin X, Song Y, Deng W, Blake N, Luo X, Meng J. Potential predictive biomarkers in antitumor immunotherapy: navigating the future of antitumor treatment and immune checkpoint inhibitor efficacy [Review]. Front Oncol. 2024. https:\/\/doi.org\/10.3389\/fonc.2024.1483454.","journal-title":"Front Oncol"},{"key":"3396_CR223","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02186-6","author":"X Ying","year":"2024","unstructured":"Ying X, Chen Q, Yang Y, Wu Z, Zeng W, Miao C, et al. Nanomedicines harnessing cGAS-STING pathway: sparking immune revitalization to transform \u2018cold\u2019 tumors into \u2018hot\u2019 tumors. Mol Cancer. 2024. https:\/\/doi.org\/10.1186\/s12943-024-02186-6.","journal-title":"Mol Cancer."},{"issue":"8","key":"3396_CR224","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012089","volume":"13","author":"H Yu","year":"2025","unstructured":"Yu H, Magoulopoulou A, Amini R-M, Chatzinikolaou MP, Horie M, Lindberg A, et al. Spatial TCR clonality and clonal expansion in the in situ microenvironment of non-small cell lung cancer. J Immunother Cancer. 2025;13(8):e012089. https:\/\/doi.org\/10.1136\/jitc-2025-012089.","journal-title":"J Immunother Cancer"},{"key":"3396_CR225","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1174713","author":"L Yu","year":"2023","unstructured":"Yu L, Xie H, Wang L, Cheng M, Liu J, Xu J, et al. Microwave ablation induces abscopal effect via enhanced systemic antitumor immunity in colorectal cancer. Front Oncolo. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1174713.","journal-title":"Front Oncolo."},{"issue":"6","key":"3396_CR226","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.7150\/ijbs.91771","volume":"20","author":"X Yu","year":"2024","unstructured":"Yu X, Li W, Li Z, Wu Q, Sun S. Influence of microbiota on tumor immunotherapy. Int J Biol Sci. 2024;20(6):2264\u201394. https:\/\/doi.org\/10.7150\/ijbs.91771.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"3396_CR227","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1515\/mr-2023-0005","volume":"3","author":"Y Yu","year":"2023","unstructured":"Yu Y, Feng L, Liu Z. Nanomedicine sheds new light on cancer immunotherapy. Med Rev. 2023;3(2):188\u201392. https:\/\/doi.org\/10.1515\/mr-2023-0005.","journal-title":"Med Rev"},{"issue":"5","key":"3396_CR228","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1039\/D3MH00092C","volume":"10","author":"Z Yu","year":"2023","unstructured":"Yu Z, Wang D, Qi Y, Liu J, Zhou T, Rao W, et al. Autologous-cancer-cryoablation-mediated nanovaccine augments systematic immunotherapy. Mater Horiz. 2023;10(5):1661\u201377. https:\/\/doi.org\/10.1039\/D3MH00092C.","journal-title":"Mater Horiz"},{"key":"3396_CR229","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-03003-6","author":"S Zafar","year":"2025","unstructured":"Zafar S, Hafeez A, Shah H, Mutiullah I, Ali A, Khan K, et al. Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives. European j med res. 2025. https:\/\/doi.org\/10.1186\/s40001-025-03003-6.","journal-title":"European j med res."},{"key":"3396_CR230","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.imlet.2023.10.002","volume":"263","author":"J Zhai","year":"2023","unstructured":"Zhai J, Lv L-l, Wu J-j, Zhang Y-x, Shen Y, Qu QX, et al. Combining local cryoablation with PD-L1 blockade synergistically eradicates established murine lung cancer by modulating mitochondrial in PD-1+CD8+ T cell. Immunol Lett. 2023;263:61\u20139. https:\/\/doi.org\/10.1016\/j.imlet.2023.10.002.","journal-title":"Immunol Lett"},{"key":"3396_CR231","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.163201","volume":"514","author":"C Zhang","year":"2025","unstructured":"Zhang C, Chen Y, Yu Z, Qi Y, Xia J, Zheng H, et al. Autologous nanovaccine repolarizes tumor-associated macrophages to M1 phenotype inducing PANoptosis for lung cancer immunotherapy. Chem Eng J. 2025;514:163201. https:\/\/doi.org\/10.1016\/j.cej.2025.163201.","journal-title":"Chem Eng J"},{"key":"3396_CR232","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e36388","author":"J Zhang","year":"2024","unstructured":"Zhang J, Sun Y-d, Li Y, Han J. Application of combined ablation and immunotherapy in NSCLC and liver cancer: current status and future prospects. Heliyon. 2024. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36388.","journal-title":"Heliyon"},{"issue":"7","key":"3396_CR233","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1007\/s12010-023-04760-y","volume":"196","author":"K Zhang","year":"2024","unstructured":"Zhang K, liu M, Cong L, He X, Xu Y, Wang Q, et al. A comparative study of antitumor immunity induced by radiofrequency microwave and cryoablation in hepatocellular carcinoma. Appl Biochem Biotechnol. 2024;196(7):4088\u2013104. https:\/\/doi.org\/10.1007\/s12010-023-04760-y.","journal-title":"Appl Biochem Biotechnol"},{"key":"3396_CR234","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01492-8","author":"P Zhang","year":"2023","unstructured":"Zhang P, Zhang G, Wan X. Challenges and new technologies in adoptive cell therapy. J Hematol Oncolo. 2023. https:\/\/doi.org\/10.1186\/s13045-023-01492-8.","journal-title":"J Hematol Oncolo."},{"key":"3396_CR235","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02067-y","author":"S Zhang","year":"2023","unstructured":"Zhang S, Huang Y, Pi S, Chen H, Ye F, Wu C, et al. Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1\/PD-L1 for residual tumors immunotherapy after RFA. J Nanobiotechnol. 2023. https:\/\/doi.org\/10.1186\/s12951-023-02067-y.","journal-title":"J Nanobiotechnol"},{"issue":"13","key":"3396_CR236","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1038\/s41388-022-02201-4","volume":"41","author":"T Zhang","year":"2022","unstructured":"Zhang T, Wang Y, Li Q, Lin L, Xu C, Xue Y, et al. Mesenchymal stromal cells equipped by IFN\u03b1 empower T cells with potent anti-tumor immunity. Oncogene. 2022;41(13):1866\u201381. https:\/\/doi.org\/10.1038\/s41388-022-02201-4.","journal-title":"Oncogene"},{"key":"3396_CR237","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1258786","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li Z, Huang Y, Zou B, Xu Y. Amplifying cancer treatment: advances in tumor immunotherapy and nanoparticle-based hyperthermia. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1258786.","journal-title":"Front Immunol."},{"issue":"1","key":"3396_CR238","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01102-y","volume":"7","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Liu X, Chen D, Yu J. Radiotherapy combined with immunotherapy: the dawn of cancer treatment. Signal Transduct Target Ther. 2022;7(1):258. https:\/\/doi.org\/10.1038\/s41392-022-01102-y.","journal-title":"Signal Transduct Target Ther"},{"key":"3396_CR239","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1669796","volume":"16","author":"B Zhao","year":"2025","unstructured":"Zhao B, Wan J, Zhou H, Yang J, Wan H. Trained immunity in atherosclerosis: plasticity, metabolic-vascular axis, and AI-driven precision remodeling. Front Immunol. 2025;16:1669796. https:\/\/doi.org\/10.3389\/fimmu.2025.1669796.","journal-title":"Front Immunol"},{"key":"3396_CR240","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-023-03975-3","author":"F Zhao","year":"2023","unstructured":"Zhao F, Liu F, Wang W. Treatment progress of spinal metastatic cancer: a powerful tool for improving the quality of life of the patients. J Orthop Surg Res. 2023. https:\/\/doi.org\/10.1186\/s13018-023-03975-3.","journal-title":"J Orthop Surg Res."},{"key":"3396_CR241","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202500785","author":"S Zhao","year":"2025","unstructured":"Zhao S, Zhang Z, Wu X, Chen Y, Li WJ, Bao J, et al. Progress of immune-inducible biomaterials for post-ablation cancers. Adv Healthcare Mater. 2025. https:\/\/doi.org\/10.1002\/adhm.202500785.","journal-title":"Adv Healthcare Mater."},{"key":"3396_CR242","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1339213","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Yang T, Ouyang Y, Rao W, Liu K, Zheng J, et al. Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinoma. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1339213.","journal-title":"Front Immunol."},{"issue":"8","key":"3396_CR243","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.7150\/jca.93885","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Bai J, Wang X, Zhang Y, Yan X, Qi J, et al. Threatment strategies for recurrent hepatocellular carcinoma patients: ablation and its combination patterns. J Cancer. 2024;15(8):2193\u2013205. https:\/\/doi.org\/10.7150\/jca.93885.","journal-title":"J Cancer"},{"issue":"1","key":"3396_CR244","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-024-00543-1","volume":"13","author":"S Zheng","year":"2024","unstructured":"Zheng S, Wang W, Shen L, Yao Y, Xia W, Ni C. Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies. Exp Hematol Oncol. 2024;13(1):80\u201380. https:\/\/doi.org\/10.1186\/s40164-024-00543-1.","journal-title":"Exp Hematol Oncol"},{"key":"3396_CR245","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1139527","author":"P Zhou","year":"2023","unstructured":"Zhou P, Wang Y, Qin S, Yan H, Yang Y, Zhao L, et al. Abscopal effect triggered by radiation sequential mono-immunotherapy resulted in a complete remission of PMMR sigmoid colon cancer. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1139527.","journal-title":"Front Immunol."},{"issue":"4","key":"3396_CR246","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002343","volume":"9","author":"W Zhou","year":"2021","unstructured":"Zhou W, Yu M, Pan H, Qiu W, Wang H, Qian M, et al. Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer. J Immunother Cancer. 2021;9(4):e002343. https:\/\/doi.org\/10.1136\/jitc-2021-002343.","journal-title":"J Immunother Cancer"},{"key":"3396_CR247","doi-asserted-by":"publisher","unstructured":"Ziegler, D. A., Ambold, M., Schirmer, M., Dr\u00f6ge, L. H., Ziegler, S., Kieslich, B., Fischer, L. A., Donath, S., Bensberg, J., Leu, M., Guhlich, M., Diest, L. A. v., Braulke, F., Hammerstein\u2010Equord, A. v., Andreas, S., Rieken, S., Rittmeyer, A., & Shafie, R. A. E. (2025a). The abscopal effect in metastatic lung cancer: a retrospective analysis of combined radiotherapy and immunotherapy. Clinical & Experimental Metastasis, 42(5). https:\/\/doi.org\/10.1007\/s10585-025-10375-w","DOI":"10.1007\/s10585-025-10375-w"},{"issue":"5","key":"3396_CR248","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10585-025-10375-w","volume":"42","author":"DA Ziegler","year":"2025","unstructured":"Ziegler DA, Ambold M, Schirmer M, Dr\u00f6ge LH, Ziegler S, Kieslich B, et al. The abscopal effect in metastatic lung cancer: a retrospective analysis of combined radiotherapy and immunotherapy. Clin Exp Metastasis. 2025;42(5):56\u201356. https:\/\/doi.org\/10.1007\/s10585-025-10375-w.","journal-title":"Clin Exp Metastasis."},{"issue":"24","key":"3396_CR249","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.1182\/bloodadvances.2024012599","volume":"8","author":"\u039d \u039a\u03c9\u03c3\u03c4\u03cc\u03c0\u03bf\u03c5\u03bb\u03bf\u03c2","year":"2024","unstructured":"\u039a\u03c9\u03c3\u03c4\u03cc\u03c0\u03bf\u03c5\u03bb\u03bf\u03c2 \u039d, Costabile F, Krimitza E, Beghi S, Goia D, Perales-Linares R, et al. Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltration. Blood Adv. 2024;8(24):6308\u201320. https:\/\/doi.org\/10.1182\/bloodadvances.2024012599.","journal-title":"Blood Adv."}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03396-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03396-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03396-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:53:39Z","timestamp":1791453219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03396-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":249,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3396"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03396-2","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"30 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"313"}}